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ABSTRACT 
Skeletal muscle displays a remarkable plasticity to loading and unloading. Such load-dependence 
is illustrated by the remodelling of metabolic and myofibrillar protein composition. To date the 
earliest documented molecular adjustments in unloaded human skeletal muscle consists of pre-
translational alteration in the expression of factors regulating protein degradation and synthesis 
and mitochondrial metabolism. In project one I set out to investigate the changes in protein 
expression in the soleus and vastus lateralis muscle, muscles involved in posture and movement, 
after three days of unilateral limb suspension. My findings suggest that early unloading alters 
FAK-pY397 and metavinculin content, and deregulate the expression of factors that set the slow-
oxidative phenotype. The underlying mechanisms governing disuse atrophy have not been 
characterized. Therefore, in the second project I examined muscle fibre morphology and 
potential factors associated with anabolic signalling as well as markers representative of the 
catabolic pathways in response to a chronic unloading period of 21 days in humans. Our findings 
support the proposition based on animal studies that mechanisms responsible for muscle atrophy 
involve a decrease in protein synthesis accompanied by an increase in protein degradation. It is 
well known that adjustments in muscle size are driven by changes in the content of myofibrils. 
However, how such myofibrillar alterations are integrated at the molecular and the architectural 
level in muscle fibres that undergo adaptive changes has not been resolved. Thus in project 3 I 
have examined changes in the content of costamere components with increased and reduced 
loading of human antigravity muscle in relation to changes in muscle size and molecular 
parameters of muscle size regulation. The findings suggest that load-dependent plasticity of 
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muscle size is integrated through costamere remodelling via a load-regulated process that 
involves level alterations of FAK and KAK-pY397 concentration.  
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1. Review: The cellular and molecular basis of skeletal muscle disuse atrophy 
 
 
1.1 Introduction: Disuse atrophy 
Skeletal muscle atrophy can occur as a result of neural injuries, aging, starvation or lack of use 
and is a co-morbidity of many chronic diseases e.g. cancer. In particular, disuse happens to be a 
major cause of muscle atrophy in humans, typically occurring among patients, inactive elderly 
and astronauts. This form of muscle loss due to reduced loading demands imposed by inactivity 
has been regarded as an appropriate beneficial adaptation for reducing total muscular energy 
requirements (Murton et al., 2008). However, such muscle mass loss can be debilitating, 
significantly affecting the activities of daily living and decreasing quality of life of individuals as 
well as endangering the well-being of astronauts.   
 
 
1.1.1 Functional and physiological changes with disuse atrophy 
In response to inactivity, skeletal muscle undergoes structural and functional adaptations 
necessary to the reduced loading demands imposed in this new environment. The major 
unloading induceddeleterious alterations typically feature the loss of muscle mass and the 
associated decline in peak force and power, such that largest losses of function occur in the low-
force-high-velocity region of the force-velocity relationship. Many of physiological changes of 
skeletal muscle associated to unloading can occur on the time scale of days or weeks (Booth and 
Thomason 1991, Flueck and Hoppeler 2003). The earliest documented molecular adjustments 
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involve pre-translational regulation of protein degradation and mitochondrial metabolism at just 
two days of disuse. The typical consequences underlying this load-dependent muscle loss 
become manifest after two weeks of unloading and consist of a distinctive muscle loss to a 
substantial degree, such that two weeks of leg-immobilization has shown an almost 5% reduction 
in quadriceps lean mass. A 20% reduction in type I muscle fibre cross sectional area and a 30% 
reduction in type II fibre area were observed following 60-days bed rest. Findings suggest that 
the extent of atrophy is muscle type specific with the greatest being observed in antigravity 
muscles, containing predominantly slow-twitch muscle fibres. Apart from the distinctive muscle 
fibre atrophy in reponse to immobilization, muscle fibres also undergo a fiber type 
transformation involving a shift from a slow-oxidative to an atrophic, fast-glycolytic phenotype, 
resulting in increased expression of fast myosin isoforms, which has been well documented in 
experiements on rodents (Desplanches et al., 1987, Fitts et al., 2000, Flueck and Hoppeler 2003), 
whereas there were few human studies in which a clear slow to fast shift in fibre-type 
distribution was observed following disuse (Hortobagyi et al., 2000, Borina et al., 2010). The 
mechanism underlying such fibre type switching represented by MHC-1-MHC-2A-MHC-2X 
shift in MHC isoform expression is not clear. However, a recent transgenic study demonstrated 
that focal adhesion kinase signaling promotes fibre type differentiation towards slow-oxidative 
muscle phenotype, whereby FAK overexpression in rat antigravitational muscle fibres 
upregulated transcript levels and protein content of MHC1 and components of mitochondrial 
respiration with a reduced expression of the major fast-type myosin heavy chain (MHC) isoform, 
MHC2A and such FAK-modulated muscle transcriptome was load-dependent (Durieux et al., 
2009). 
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1.2 Models used in studying muscle unweighting 
All data on disuse atrophy of human skeletal muscle are gathered from the utility of experimental 
designs that simulate the unloaded skeletal muscle conditions in humans. Due to extremely 
limited opportunities and sheer cost associated with space missions, several ground-based 
models of unweighting applied to study human disuse atrophy were first introduced as cost-
effective and less time consuming alternatives to mimic the microgravity environment of space. 
These ground-based models are useful in the way to provide basic experimental design elements 
including control subjects as well as the ability to regulate variables like diet and exercise and 
they prove to be successful surrogates for providing valuable insights into disuse atrophy since 
the changes of musculoskeletal system appear similar to that in real situations. Below is a general 
overview of the effectiveness of the three different human models of unloading with particular 
consideration for the practicalaspects of each of the models based on their own unique 
characteristics. 
 
 
1.2.1 Overview: Bed rest 
Bed rest was established to be the principle ground-based model for mimicking the effects of 
microgravity during spaceflight on the musculoskeletal system. The particular version of the 
model involving head-down tilt successfully reproduces many of the associated cardiovascular 
and skeletal muscle-related aspects of the adaptation to microgravity (Adams et al., 2003). This 
model specifically induces unloading of the whole body hence effectively imposes inactivity on 
all postural body structures and tissues and generates a significant decrement in activity as well 
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as energy expenditure. Generally, results available to date from bed rest studies have compared 
favorably with those obtained from spaceflight. In the context of skeletal muscle physiology, 
both conditions share the same regulatory mechanisms for unweighting-induced adaptations, 
which concern the notion that much of the effect of altered loading stimulus on muscle is of a 
locally mediated response, initiated through mechanisms intrinsic to the muscle itself (Adams et 
al., 2003). The extent of the adaptive response is dependent on the degree of changes in loading 
experienced by particular muscle groups, i.e.postural muscles with antigravity functions will be 
primarily affected (LeBlanc et al., 1988, LeBlanc et al., 1995). Overall, the majority of the 
findings from literature suggest that the magnitude of alterations in size and performance in 
response to bed rest are consistent with those seen with space flight. A couple of potential 
cautionary issues in association with the intervention need to be addressed. Firstly, after 
relatively short periods of bed rest markers of increased bone resorption can be detected (Lueken 
et al., 1993, Smith et al., 1998). Secondly, there has been evidence to indicate a certain degree of 
cardiovascular deconditioning following bed rest (Levine et al., 1997, Pawelczyk et al., 2001, 
Perhonen et al., 2001). This model imposes unweighting on all postural muscles as a result 
participants will require to follow a comprehensive programme of rehabilitation afterwards 
(Adams et al., 2003). Practically, bed rest studies involve a substantial amount of resources, such 
as specialized bed rest facilities that have showers to accommodate gurneys and the need for 24-
hour nursing supervision (Widrick et al., 1997, Koryak 1998). Taking these above mentioned 
implications into consideration, it is questionable as to whether the use of this model is 
appropriate in situations where research interests just focus on the effects of unweighting on one 
or a few muscle groups. The fact that this intervention is particularly well suited for studying 
relatively complete whole body unweighting has restricted the application of this model to only 
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integrated musculoskeletal and cardiovascular investigations designed for studying multisystem 
effects of reduced activity (Adams et al., 2003). 
 
 
1.2.2 Overview: Immobilization 
Limb immobilization (IM) is another model that has been used to study disuse atrophy. This 
approach comprises lower limb casting, which involves the targeted limb being fixed with the 
knee joint in a flexed position. While carrying out ambulatory activities through the use of 
crutches the immobilized limb is floating above the ground. Data from strength measurements 
suggests that IM appears to induce a somewhat more rapid decline in maximum voluntary 
contraction performance compared to that during spaceflight and bed rest (Adams et al., 2003). 
Associated with this, IM findings indicates also a more rapid decline in muscle or muscle group 
size (cross-sectional area) (Adams et al., 2003). In terms of muscle fibre size measurements, 
there are only three reports in the literature for healthy IM subjects (Hespel et al., 2001, 
Hortobagyi et al., 2000, Veldhuizen et al., 1993). Amongst the existing data reported, already 14 
days of IM resulted in muscle fibre CSA decrements of 8% for type I, 11% for type IIa and 9% 
for IIb.  
Generally, mechanisms that underlie IM–induced muscle adaptations appear similar to those 
induced by spaceflight in which the postural antigravity muscles are to experience the greatest 
effect (Adams et al., 2003). The only deviation of this IM model from the other two models is 
the fixation of the knee joint. This added impact of the fixation might result in the more rapid 
change seen in IM in comparison to during spaceflight and bed rest. However, it is important to 
note that majority of IM data available to date are based on shorter durations and there are no 
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data after 28 days of IM.  The fact of a lack of longer-period observations renders such 
conclusion of potential differences in response between IM, spaceflight and bed rest open to 
question. The immobilization model is specifically aimed at studying unloading-induced atrophy 
of skeletal muscle; the model induces inactivity to a certain extent, but mainly targets muscles in 
the suspended limb. This is advantageous for practical applications as participants can remain 
relatively active compared with e.g. bed rest models. Moreover, the resources in terms of 
facilities, equipment and personnel necessary to conduct IM studies are modest.  
In contrast to that observed in space flight and bed rest IM limits adaptive response to only 
muscles in the suspended limb, avoiding problems associated with cephalad fluid shifts (Adams 
et al., 2003). Caution should be taken during the ambulatory period due to the possibility of 
falling associated with limb suspension and in cases involving improper use of crutches where 
axillary injuries may happen. There is a small risk of thrombosis (Bleeker et al., 2004), however, 
the overall risks associated with this intervention is low.  
 
 
1.2.3 Overview: Unilateral limb suspension  
Unilateral limb suspension (ULLS) is similar to the IM model in the way that it involves 
immobilization of the lower limb with unweighting of just one leg while the contralateral limb 
remains loaded. There happen to be two forms of the model.The older version employs the use of 
a support strap to suspend the target limb whereas the more recent one incorporates the use of a 
high-platform shoe for the loading leg (Berg et al., 1991, Ferretti et al., 2001). In each case, 
weight bearing is prevented on the targeted leg and individuals carry out ambulatory activity via 
the use of crutches. On the contrary to IM, ULLS does not involve constant fixation of the knee 
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joint. However, it should be noted that in the strap model, there is an element of knee flexion 
involved to certain extent, depending on the amount of time individuals spend in ambulatory 
activity, the associated changes in muscle strength is likely to simulate those postulated for IM 
due to the knee joint being in a flexed position. Interestingly, the actual findings from studies 
using the strap version of the ULLS model have demonstrated the observed changes in muscle 
strength to rather correspond to those data from space flight and bed rest. Therefore, the 
accelerated loss of strength as suggested previously in the IM section does not seem to take place 
after the periods of possible knee joint fixation involved in this model (Adams et al., 2003). The 
selective unloading of the treatment limb results in the adaptive responses to limit to affected 
muscles, such that the antigravity muscles of the leg experiences a greater reduction in muscle 
size compared to those of the thigh. The fact that the model has been developed relatively recent 
has lead to a very few number of muscle fibre size reports being available to date (Adams et al., 
2003). Even though the existing fibre size alterations seems to be in accordance with those 
reported in space and bed rest, given the scarcity of results on this measurement factor it is not 
possible yet to determine whether the findings demonstrate a response that is comparable with 
the spaceflight or bed rest data. Furthermore, a recent report suggests that ULLS is not an 
appropriate model for spaceflight/bed rest induced alterations at the single-fibre level in skeletal 
muscle. However, such conclusions were reached based on comparisons made between fibres 
from a ULLS study with those from bed rest and spaceflight studies that included exercise 
countermeasures as part of the intervention, which raises questions as to whether such 
assessment forms a valid basis for evaluating the usefulness of the ULLS model (Baldwin et al., 
1996, Riley et al., 1998, Riley et al., 2000, Widrick et al., 2002). Data indicate that the general 
mechanism governing ULLS induced changes conforms to the criteria of local effect rather than 
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effects of systemic phenomena, which are uniform to those observed in bed rest and spaceflight 
studies (Ferretti et al., 2001). For practical considerations, ULLS does prove to be a good model 
for studying local effects of unloading exclusively in skeletal muscle. Very little resources are 
required for conducting an ULLS study, in a way similar to IM, which is substantially less than 
those necessary for bed rest (Adams et al., 2003). The fact that ULLS model maintains lower 
limbs in normal anatomic positions for majority of the time allows participants to perform most 
occupational activities without compromising the study (Berg and Tesch 1996). In particular, the 
feature of unfixed knee joint in the platform shoe version enables participants to even achieve 
free range of limb motion in the targeted limb when performing ambulatory activities, as a result 
the direction of changes shown by the muscle size and functional data suggest responses to 
ULLS may more directly mimic spaceflight than those from the IM model (Dudley et al., 1992, 
Ploutz-Snyder et al., 1995, Ploutz-Snyder et al., 1996, Ferretti et al., 2001, Adams 2002). Such 
periods of upright posture and the maintenance of relatively normal activity level majority of 
musculoskeletal system to remain loaded can successfully ameliorate the side effects imposed by 
relatively sedentary models including cardiovascular deconditioning (Adams et al., 2003). 
Moreover, the concern over falling during ambulatory activity with ULLS is considerably 
reduced in contrast to IM since there is the unloaded limb available to use in cases when balance 
is lost. A lone report has highlighted a risk of developing venous thrombosis in the calf following 
ULLS (Berg and Tesch 1996). This adverse event happened only in two of the subjects and 
appears to be a function of the attendant restriction of movement associating with the strap 
version of the model, through eliminating the strap element in the model have resolved this 
problem (Dudley et al., 1992, Ploutz-Snyder et al., 1995, Ploutz-Snyder et al., 1996, Ferretti et 
al., 2001, Adams 2002). Overall, like that of IM it is not sufficient for investigating 
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cardiovascular and whole body adaptation since it does not cause cephalad fluid shiftbut would 
rather represent an appropriate model to use for studying aspects of skeletal muscle specific 
unweighting. In our studies where ULLS was used, we have tried to limit the risk of thrombosis 
by keeping the knee joint in a slightly flexed position.  
 
 
 
Figure 1.1 Model of unilateral limb suspension, with a left shoe with thick sole and the shoulder 
strap running around foot and ankle to unload the right foot 
 
 
1.2.4 Evaluation of models 
All of the three models discussed above can effectively bring aboutthe unloading-induced 
adaptations in skeletal muscle. Despite their impact on muscle fibres being of different degrees 
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of severity and/or rapidity, the overall response appears quite similar. The analysis of the data 
sets available on measured muscle physiological parameters including muscle size and strength 
performance do not favor the selection of one of the reviewed models over another. For selecting 
a specific model investigators should consider primarily the unique characteristics of each of the 
three models outlined in relation to the specific aims of a given study together with 
considerations for the more practical aspects of the models.  
 
 
1.3 Proposed mechanisms governing disuse muscle atrophy 
Skeletal muscle demonstrates a pronounced plasticity in response to loading status, which 
include remodeling of the contractile properties and metabolic capacities of individual muscle 
fibres (Booth 1991, Flueck and Hoppeler 2003). While the adaptations of skeletal muscle to 
changes in mechanical stimuli have been well documented, there is currently a lack of cellular 
and molecular understanding of such adjustments, especially regarding the underlying 
mechanisms. A very recent human study investigating the early events of unloading has reported 
the existence of differential gene expression patterns between muscle types, which are suggestive 
of regulatory mechanisms being possibly influenced by muscle phenotype and function 
(Gustafsson et al., 2010). In simple terms, the loss of muscle mass is the result of an imbalance 
between anabolic and catabolic regulations, favoring for an increased proteolysis and/or a 
decreased protein synthesis. Despite the fact that a variety of triggers and signaling proteins has 
been studied for a role in disuse atrophy, the cascade of signaling events that promotes the 
altered rate of protein turnover through anabolism or catabolism or both is still not clear. Based 
on animal unloading studies, protein degradation seems to be the major cause of muscle mass 
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loss, however, recent human isotope labeling experiments have lead to the proposition that the 
muscle atrophy in response to human disuse conditions is primarily the result of a decrease in 
muscle protein synthesis rather than an increase in protein degradation (de Boer et al., 2007a, 
Rennie et al., 2008). Reports of phosphorylation of specific translation factors at critical amino 
acids from unloading studies support the physiological regulation of protein synthesis as a 
control of muscle mass (Sandri 2008). At least modulated protein synthesis has been proposed by 
many to be the main mechanism underlying early regulations of load-dependent muscle protein 
turnover. In the review to follow, identified mechanisms are discussed with reference to key 
factors.  
 
 
1.4 Anabolic signaling  
 
 
1.4.1 The role of insulin-like growth factor 1 (IGF-1)/phophatidylinositol-3 kinase 
(PI3K)/AKT (Protein kinase B) pathway in disuse atrophy  
The most well documented molecular pathway responsible for protein synthesis to date is the 
IGF-1/PI3K/Akt/ pathway. Insulin-like growth factor (IGF-1) activates the PI3K/Akt pathway 
necessary for the initiation of protein translation during mechanical loading of the muscle. The 
down-stream signalling cascade involves phosphoinositide-3-kinase (PI3K)-induced initial 
phosphorylation of protein kinase B (Akt) that in turn activates mammalian target of rapamycin 
(mTOR) and a number of its downstream effectors including p70 ribosomal protein S6 kinase 
(p70S6K) and translation initiation factors such as eIF4e-BP1 and eEF2 (Bodine et al., 2001b, 
Gingras et al., 2001, Pallafacchina et al., 2002, Deldicque et al., 2008, Sandri 2008). IGF-1 was 
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first suggested as an autocrine-paracrine anabolic factor produced by the muscle in a functional 
overload model, by Goldberg (1967). It was demonstrated that IGF-1 mRNA levels within the 
muscle increased in response to the load. This finding has been later confirmed by other 
investigators. Then, IGF-1 overexpression has been shown to increase muscle mass with 
concurrent activation of the Akt/mTOR signalling pathway (Barton 2006). Although animal 
studies indicate that the Akt/mTOR protein anabolic pathway seems to be down-regulated during 
unloading (Bodine et al., 2001b), its involvement in the human state of disuse atrophy has been 
questioned.  
It has been generally agreed that mechanical stimuli can lead to increased protein synthesis via 
two initial triggers, increased growth factor concentration or direct mechanical tension. 
Akt/mTOR signaling integrates the growth factor-dependent control of muscle mass, whereas the 
latter form of stimulation has not been well characterized. At the moment there is strong 
evidence to support the presence of a load-dependent anabolic signaling pathway in skeletal 
muscle (Klossner et al., 2009). However, the signalling elements of this mechano-sensory 
pathway remain to be elucidated.    
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Figure 1.2  Model summarizing Insulin-like growth factor I (IGF-I)-mediated signalling 
pathways relevant to skeletal muscle hypertrophy and the Akt-independent FAK-mediated 
mechanical signalling towards enhanced protein translation via p70S6K (Klossner et al., 2009). 
Abbreviations: IGF-1, insulin-like growth factor 1; PI3K, phophatidylinositol-3 kinase; Akt, 
Protein kinase B; mTOR, mammalian target of rapamycin; FAK, focal adhesion kinase; p70S6K, 
p70 S6 kinase. 
 
 
1.4.2 Costameres and its link to mechanotransduction  
There is currently a limited understanding of the critical molecular events underlying the 
integration of mechanical signals toward downstream muscle protein synthesis responses. 
Attentions have been focused on mediators that are sensitive to mechanical stimuli, as these 
factors are most likely to contribute to signal transduction. In skeletal muscle, subsarcolemmal 
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focal adhesion assemblies known as costameres circumferentially align in register with the Z-
disk of peripheral myofibrils, structurally link muscle fibres via the surrounding extracellular 
matrix to adjacent muscle fibres (Ervasti 2003). Consequently, given their location and 
associations costameres function to transmit contractile force laterally from the myofibrils across 
the sarcolemma to the extracellular matrix (ECM), serving to maintain the spatial organization of 
myofibrils as well as to insure the integrity of muscle fibres during contraction while physically 
couple force-generating sarcomeres with the sarcolemma. These costameres have been 
recognised as key structures for the myofascial transmission of forces. Indeed, it has been well 
known that costameric protein expression, stability and organization are closely regulated by 
mechanical tension (Quach and Rando 2006). Data currently supports the idea that costamere 
regulation plays a role in load-dependent muscle remodeling. Studies have demonstrated that 
costameric protein expression changes are associated with changes in muscle size in both animal 
and human loading and unloading models (Chopard et al., 2005, Durieux et al., 2007, Durieux et 
al., 2009). An in vitro skeletal myogenesis study of cultured differentiated skeletal muscle cells 
has shown that the formation and organization of aligned myofibrils is tightly coupled to 
costamerigenesis during skeletal myogenesis partly through contractile function and requires 
FAK signaling (Quach and Rando 2006). Furthermore, in vivo and in vitro data suggest that 
mechanosensitive protein complexes contained within costameres constitute potential sites for 
the conversion of contraction forces into mechano-sensitive signalling inside the myocellular 
compartments (Huijing et al., 1999, Bloch and Gonzalez-Serratos 2003, Samarel 2005, Quach 
and Rando 2006, Erskine et al., 2012). The suggestion that costameres are potential sites for 
mechanotransduction is supported in particular by load-dependent regulation of the amount and 
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activation status of the focal adhesion kinase (FAK) (Flueck et al., 1999, Flueck et al., 2002, 
Samarel 2005, Romer et al., 2006, Klossner et al., 2009). 
 
 
1.4.3 Focal adhesion kinase (FAK) and mechano-dependent anabolic signaling  
FAK is an integrin-bound cytoplasmic non-receptor tyrosine kinase that functions to transmit bi-
directional signals at focal adhesions between ECM and the intracellular milieu. Its tyrosine 
phosphorylation at residue 397 represents the mechano-chemical coupling between mechanical 
stimulation of integrins and activation of intracellular signal transduction (Shyy and chien 1997, 
Flueck et al., 2002, Parsons 2003, Samarel et al., 2005, Ingber 2006, Romer et al., 2006). Briefly, 
FAK activation is primarily induced upon binding of integrins to ECM ligands. The resulting 
integrin clustering at focal adhesion complexes subsequently causes FAK auto-phosphorylation 
at Tyr-397 (Schlaepfer et al., 2004). This phosphorylation creates docking sites for proteins 
including Src-family kinases which further phosphorylate FAK at several other tyrosines such as 
Tyr 576/577, enabling FAK to achieve its full catalytic activity and to establish interactions with 
intracellular signaling cascades (Calalb et al., 1995, Parsons 2003). The mechanosensing 
property of FAK is especially illustrated by the observation of the immediate activation of FAK 
along with its downstream signaling components taking place within minutes after the 
deformation of integrins by mechanical tension. 
The functional involvement of FAK in myogenesis and mechanosensing has been well 
documented in vivo and in vitro. Increased level of phosphorylated FAK was initially observed 
during chronic overload in rodents or synergist ablation in avian muscle. Conversely, a reduced 
level was reported with hindlimb suspension in rodents (Flueck et al., 1999, Gordon et al., 2001). 
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The phosphotransfer activity of FAK is stringently controlled by the magnitude of loading status. 
A 4-fold increase of FAK tyrosine phosphorylation has been reported in rat soleus muscle after 1 
day of functional overload, whereas 7 days of muscle unloading through hindlimb suspension 
has induced a 10-fold reduction in phosphorylated FAK from the same muscle type. The 
distribution of sarcolemmal concentration of FAK is dependent on the degree of muscle fibre 
recruitment for contraction, with the highest level present in slow-oxidative muscles (Gordon et 
al., 2001, Flueck et al., 2002). In support of this idea, FAK has been recognized as a load-
dependent regulator controlling the expression programme underlying the slow-oxidative 
phenotype in rat muscle (Durieux et al., 2009). Moreover, the altered level and phosphorylation 
of FAK have often been observed to associate with changes in myofibrillar content (Flueck et al., 
1999, Carson and Wei 2000). In vitro, Rando and colleagues have found that FAK signaling is 
essential in directing myofibrillogenesis partly through contractile function during skeletal 
myogenesis in cultured differentiated skeletal muscle cells (Quach and Rando 2006). These 
observations suggest that FAK could be a load-dependent regulator of protein synthesis. p70S6K 
positioned downstream of FAK in cell culture is regarded as a potential effector of FAK 
activation since the phosphotransfer activity and phosphorylation status of both kinases correlate 
with protein synthesis and load-dependent increases in muscle mass, suggesting a possible 
functional coupling between the two kinases (Malik and Parsons 1996, Cary and Guan 1999, 
Flueck et al., 2002, Gan et al., 2006, Ingber 2006). Recently, a muscle-targeted transgenesis 
study in rat has identified FAK as an upstream regulator of p70s6k activation in a mechano-
sensory anabolic pathway that is AKT-independent (Klossner et al., 2009). 
Nevertheless, majority of the data on FAK signaling in muscle remodeling were obtained from 
cell lines and rodents. To date, few studies have examined the effect of mechanical loading state 
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on FAK in human skeletal muscle. Currently, only two human disuse studies have looked at 
FAK. De Boer and colleagues reported a 30% decrease in FAK phosphorylation at Tyr 576/577 
and a 20% decrease in its content after 10 days of ULLS, with no apparent change in rest of the 
signaling proteins that they have measured (de Boer et al., 2007b). The other study has detected 
a reduced level of phosphorylated FAK (Tyr 576/577) as the most evident change after 14 days 
of unilateral knee immobilization. The author has suggested that much of the immobilization-
induced muscle loss observed was the result of a decline in post–absorptive muscle protein 
synthesis (Glover et al., 2008).  
Overall, above findings point to FAK’s function as an upstream regulatory molecule of a 
mechano-sensory pathway involved in anabolic signaling. 
 
 
1.4.4 mTOR and p70S6K  
One of the best-investigated downstream effectors of intracellular anabolic signaling in skeletal 
muscles is 70kDa ribosomal S6 kinase (p70S6K), a serine/threonine kinase with a well 
established role of promoting increased translational efficiency as well as translation capacity 
(Ruvinsky and Meyuhas 2006). Over the past 20 years, the cellular regulation and function of 
S6K as part of the anabolic signaling network has been widely studied. In particular, a great deal 
has learnt in regard to its association with the AKT/mTOR pathway. 
In mammals, S6K represent a family composed of two distinct genes, S6K1 and S6K2, both of 
which encode two protein isoforms each generated by alternate ATG start site utilization. Among 
the isoforms, the 70kDA S6K1/p70S6K containing 502 amino acids has been the best 
characterized and most extensively studied protein, with a function in translational control. Its 
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activity is regulated by phosphorylation and dephosphorylation events. In its activated form, 
p70S6K phosphorylates the ribosomal protein S6 on five serine residues in the C-terminal tail, 
which then promotes the possible translation of a class of around 90 transcripts known as 5’TOP 
(terminal oligopyrimidine tract) mRNAs that are known to encode a variety of ribosomal 
proteins and translation factors. In addition, active S6K1 generated through dissociation from the 
multi-subunit scaffold eIF3 upon mTOR binding also phosphorylates a group of substrates 
involved in translation initiation or other steps for driving protein production (Ruvinsky and 
Meyuhas 2006, Zanchi and Lancha 2008, Fenton and Gout 2011, Magnuson et al., 2012). 
The initial recognition of the critical nature of p70S6K in skeletal muscle is through the 
observation of significantly reduced cross sectional area of the individual muscle fibres in 
p70S6K-/- mice where S6K1 was genetically ablated compared to that of fibres from the wild-
type animals (Ohanna et al., 2005). It has been widely accepted that the phosphorylaton of 
p70S6K at the 389 threonine site marks the increased protein anabolic response induced by 
mechanical stimulation (Baar and Esser 1999). Significantly elevated phosphorylation of 
p70S6K at Threonine 389 has been observed to correlate with increased muscle mass during 
loading protocols in rodents (Baar and Esser 1999, Nader and Esser 2001, Atherton et al., 2005, 
Burry et al., 2007). In line with the animal studies, elevations of activated p70S6K and its protein 
content have been reported to correlate with load-induced muscle mass increase as well as 
elevated protein synthesis from human studies of reloading (Hernandez et al., 2000, Cuthbertson 
et al., 2006, Dreyer et al., 2006, Eliasson et al., 2006, Fujita et al., 2007).  
Among the upstream signaling pathways that regulates p70S6K, only one major pathway has 
been widely accepted, which is the phosphoinositide 3-kinase (PI3K)/Akt signalling cascade. 
This pathway is initiated by activation of PI3K, which then phosphorylates Akt and leads to the 
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activation of mTOR to enhance translational efficiency in part via inducing the downstream 
effector, S6K1. The involvement of this pathway in mechano-dependent anabolic signaling has 
been questioned. Firstly, S6K1 is capable to be activated by mechanical stimuli in the presence 
of an inhibitor of PI3K, Wortmannin (Hornberger and Chien 2006). In addition, recent studies 
have shown phosphorylation of S6K1 even in the absence of activated signaling components of 
PI3K/Akt/mTOR pathway (Eliasson et al., 2006, Fujita et al., 2007, Mascher et al., 2007, 
Deldicque et al., 2008, Terzis et al., 2008). Moreover, in an attempt to restore muscle mass 
PI3K-Akt activation was recovered but failed to attenuate the loss of muscle mass induced by 
unloading (Dupont et al., 2011). Mechanical stimuli happens to induce the phosphorylation event 
of mTOR at its 2448 serine residue which then leads to activations of several effectors including 
S6K1 (Reynolds et al., 2002). While mTOR/S6K1 signaling appears to be necessary for 
hypertrophy, the inhibition of this pathway by rapamycin does not induce significant muscle 
atrophy in adult animals. In fact, whether mTOR phosphorylation at Ser 2448 represents a 
positive, negative or inconsequential regulatory phosphorylation still remain unresolved. Recent 
studies with human subjects focusing on mechanical stimulation of the skeletal muscle have 
demonstrated that the activation of p70S6K (phosphorylation in threonine 389) is not always 
correlated with the activation of mTOR (phosphorylation in serine 2448) (Eliasson et al., 2006, 
Fujita et al., 2007). Three studies so far have assessed the effects of mechanical stimulation on 
another phosphorylation site, Ser 2481 of mTOR and no alterations were observed (Eliasson et 
al., 2006, Hornberger and Chien 2006, Mascher et al., 2007). The activation of mTOR seems not 
always a prerequisite for S6K1 phosphorylation and as a result studies have already begun to 
question the dependence of mTOR on p70S6K activation (Chiang and Abraham 2005, Holz and 
Blenis 2005, Mascher et al., 2007).  
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By taking these findings into consideration alternative mechano-sensitive pathway governing 
protein synthesis is present besides the Akt-mTOR pathway. Although mTOR is a regulator of 
S6K1 signaling, mediators of S6K1 activation in response to mechanical stimuli are not yet 
identified. However more recently a muscle-targeted transgenesis study in rat with a 
physiological model for hindlimb unloading and reloading has identified a mechano-sensory 
anabolic pathway that involves FAK as an upstream element to p70S6K (Klossner et al., 2009). 
 
 
1.5 Catabolic pathways 
In simplest terms, muscle mass loss is the result of decreased protein synthesis and/or increased 
protein degradation. Therefore to characterize the mechanisms underlying muscle atrophy an 
understanding of the implications of proteolytic systems is needed. The four main proteolytic 
pathways responsible for the cellular protein degradation seen in eukaryotic cells are cysteine-
dependent aspartate specific proteases (caspases), cathepsins, calcium-dependent calpains, and 
the ubiquitin proteasome system (UPS), amongst which UPS appears to be the major proteolytic 
machinery involved in muscle protein breakdown, having its regulation being well documented 
in multiple types of muscle atrophy (Ventadour and Attaix 2006, Murton et al., 2008), yet 
evidences also suggest calpains, lysosomes and in some conditions even caspases to participate 
in muscle wasting (Berthon et al., 2007). The calcium-dependent calpains and caspase systems 
possibly play a role in initiating myofibrillar proteolysis, whereas the UPS is believed to degrade 
actin and MHC. Although all of the above mentioned proteolytic systems have been shown to be 
involved in the degradation of muscle protein during hindlimb unloading, a substantial amount of 
evidence from cell lines and animals to date supports the importance of UPS to unloading-
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induced atrophy. However recent data are just beginning to shed light on its involvement in 
human muscle remodeling. Moreover, there is very limited data on the role of lysosomal 
proteolysis in muscle atrophy. 
 
 
1.5.1 Ubiquitin-proteasome system (UPS) 
In brief, the ATP-dependent ubiquitin-proteasome proteolytic process involves two distinct 
stages, namely the addition of ubiquitin (Ub) molecules to targeting proteins termed 
ubiquitination and the subsequent recognition of the ubiquitinylated substrates by proteasome for 
hydrolysis. The ubiquitination mechanism is coordinated by actions of three distinct groups of 
enzymes. The initial step of this cascade involves the binding of Ub to Ub-activating enzyme (E1) 
through a high-energy thioester bond. Then the formation of another thioester linkage between 
Ub and a cysteine residue of Ub-conjugating enzyme (E2) enables the successful transfer of Ub 
from E1 to E2. The third enzyme, Ub-ligase enzyme (E3) functions to catalyse the last step of 
ubiquitination whereby Ub is to establish an isopeptide bond with the target protein commonly 
between the ε-amino group of a lysine residue in the target protein and the carboxy-terminal 
glycine residue 76 in Ub with only a few exceptions (Passmore and Barford 2004, Hoeller et al., 
2007, Li et al., 2007). These steps are repeated until the typical formation of a minimum of four 
Ub monomers having covalently attached via lysine residue 48 of Ub to the target protein is 
achieved as a prerequisite for the subsequent proteasomal hydrolysis (Thrower et al., 2000). This 
programme of ubiquitin transfer is an effective strategy for specifically targeting protein families 
to generate great substrate specificity. Upon recognition of the ubiquitinylated proteins by 26S 
proteasome for hydrolysis the protein substrate will unfold and enter the proteasome by means of 
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an ATP-dependent process. Structurally the 26S proteasome constitutes a 20S catalytic core and 
19S regulatory caps, where the 20S core is formed by four heptameric rings consisting of alpha 
subunits to provide structural support and beta subunits in charge of the chymotrypsin-like, 
trypsin-like and caspase-like activities (Rivett et al., 1997, Attaix et al., 2003). The tagged 
proteins are cleaved into short oligonucleotides inside the proteasome. UPS functions to degrade 
non-intact myofibrils that are (partially) disintegrated through the action of calpains (Solomon 
and Goldberg 1996, Jagoe and Goldberg 2001). 
While the literature largely explores the convergent role of the UPS components in a variety of 
atrophic conditions, its particular involvement in muscle disuse atrophy has been extensively 
investigated. Based on animal unloading data ubiquitin-proteasome system seems to be the 
mechanism responsible for the bulk of myofibrillar protein breakdown (Jackman and Kandarian 
2004). Inhibition of proteasome function with available proteasome inhibitors since 1994 proved 
to significantly affect muscle proteolysis during disuse muscle atrophy. Signs indicative of UPS 
regulation have been recognized at various levels of the proteolytic cascade. A general 
upregulation of expression of mRNAs encoding distinct UPS constituents including many 
components of 26S proteasome and its subunits have been well documented in animal unloading 
models. A distinctive increase in the mRNA levels of E3 Ub-ligases, MAFbx and MuRF1was 
reported in particular (Murton et al., 2008). Other measured variables such as the ubiquitination 
rate and the level of ubiqutinated and polyubquitinated proteins have also been observed to 
increase. By examining the proteolytic activities of the 26S proteasome an elevated activity of 
chymotrypsin has been reportedly mentioned in response to several rat unloading regimes 
including hindlimb suspension, hindlimb casting and Achilles tendon laceration (tenotomy) 
(Berthon et al., 2007, Bialek et al., 2011). In vivo data revealed that activities of 26S proteasome 
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were differentially activated in slow and fast muscles in response to inhibition-induced 
proteolysis, it was shown that the activity of 26S proteasome was 50% increased in the 
gastronemius muscle during proteolysis, while, though not significantly so, the activity was 
decreased by 25% in the soleus muscle (Shi et al., 2009).  
Overall, these findings indicate that UPS potentially accounts for the associated decrease in 
muscle mass often observed in conjunction with animal disuse studies. While other elements 
notably mRNA levels of 20S proteasome subunit alpha-4 (HC6) and amounts of ubiquitinated 
proteins appear elevated, to date most of human disuse studies have focused their attention 
generally on the transcriptional expressions of two ubiquitin ligases, MAFbx and MuRF1 
(Murton et al., 2008). 
 
 
 
Figure 1.4 UPS mediated protein degradation. Diagrammatical representation of the UPS 
detailing the activation and conjugation of free Ub onto Ub-ligase targeted protein and 
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subsequent degradation by the 26S proteasome (Murton et al., 2008). Abbreviation: Ub, 
ubiquitin molecules; E1, Ub-activating enzyme; E2, Ub-conjugating enzyme; E3, Ub-ligase 
enzyme (ie. MAFbx and MuRF1). 
 
 
1.5.1.1 MAFbx and MuRF1  
The two muscle specific E3 ligases, F-box containing ubiquitin protein ligase (atrogin-1/MAFbx ) 
and muscle RING finger 1 (MuRF1), were first identified and recognized as regulators 
responsible for muscle protein degradation under atrophy-stimulating conditions following 
transcript profiling in 2001. The discovery of atrogin-1/MAFbx was coincidentally achieved by 
two groups. One group has found through cDNA microarray analysis a unique gene fragment, 
which they named atrogin-1 being induced more than nine-fold in atrophying muscles of fasted 
mice. Whereas another study has applied the Gene-Tag differential display approach to select 
transcripts that were differentially regulated in immobilized rat muscle compared to the control 
muscle. These transcripts were then assayed for universality by Northern analysis using panels of 
mRNA prepared from muscles subjected to denervation, immobilization or unweighting from 
periods of 1 to 14 days. Two genes, MuRF1 (Muscle RING Finger 1) and MAFbx (Muscle 
Atrophy F-box), were found to be upregulated in all three models of atrophy and later analysis of 
rat and human tissues revealed their expression only in cardiac and skeletal muscles (Bodine et 
al., 2001a, Gomes et al., 2001). Subsequent knock-out studies have shown that inhibition of 
either ubiquitin ligases has markedly attenuated the amount of muscle loss. Through differential 
expression screening studies upregulated MAFbx and MuRF1 levels were detected in multiple 
models of muscle atrophy. Overall, their elevated expressions coexisted in 13 distinct animal 
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models of muscle atrophy, including hind limb suspension and denervation (Bodine et al., 2001a, 
Gomes et al., 2001, Dehoux et al., 2003, Li et al., 2003, Deruisseau et al., 2005, Latres et al., 
2005). A great amount of attention has been placed upon atrogin-1/MAFbx in the hope that they 
might serve as potential targets for pharmacologic intervention. 
E3 ubiquitin ligases function to convey specificity to ubiquitination by transferring ubiquitin 
from E2 ubiquitin-conjugating enzymes to protein substrates. The targeting of E3 Ub ligases to 
their substrates is dependent on recognition of specific amino acid sequence and /or specific 
structural and phosphorylated domains. MuRF1 is characterized by its N-terminal RING-finger 
domain, which controls E3 ubiquitin-ligase activity. The current known substrates for MuRF1 in 
skeletal muscle include myosin heavy chain, creatine kinase as well as possible myofibrillar 
proteins titin, nebulin and myosin light chain II. MAFbx contains an F-box domain, a 
characteristic motif seen in a family of E3 ubiquitin ligases called the Skp1, Cullin1 and F-box-
containing complex (SCF complex). This family of proteins establishes their E3 ubiquitin ligase 
activity by binding together. With MAFbx its F-box domain enables it to interact with Skp1. 
Protein substrates for MAFbx have been suggested to include calcineurin, eIF3f and MyoD, 
however neither protein has been demonstrated to be ubiquitinated by MAFbx in atrophy-
induced muscle (Glass 2005). 
As for the control of transcriptional regulation of MAFbx and MuRF1, limited information is 
available. Although data suggest that the expression of MAFbx and MuRF1 is regulated by the 
FOXO family of transcription factors via PI3K-Akt signaling, a recent human disuse study has 
shown their elevated mRNA levels being induced by pathways other than PI3K-Akt (Gustafsson 
et al., 2010). The literature also points MuRF1 to be under the control of the nuclear factor-kB 
(NF-kB) pathway but it is unknown whether such a finding is relevant in the human situation. 
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Based from the vast majority of data on MAFbx and MuRF1, a classical upregulation of these 
two E3 ligases is consistently observed in animal models of disuse following denervation, 
hindlimb suspension, or space-flight in hibernating squirrels, mice and rats in comparison to a 
variable finding of MAFbx and MuRF1 expression changes in humans. Several human disuse 
studies have detected an upregulated transcription of the two E3 ligases, with the earliest 
occurring after 3 days of unloading (Gustafsson et al., 2010). Others have thus far reported no 
change or even a reduction in MAFbx and MuRF1 mRNA levels (Jones et al., 2004, Ogawa et 
al., 2006, de Boer et al., 2007b, Salanova et al., 2008). The discrepancies between animal and 
human data could be accounted as the result of the severity of disuse procedures employed in 
animals being usually greater than those applied to humans (Murton et al., 2008). On the other 
hand, the number of human muscle biopsies acquired is minimized in a way to limit invasive 
procedures being employed in humans. As a result information regarding the temporal 
expression of these two ubiquitin ligases is scarce with just a lone report examining the levels of 
MAFbx and MuRF1 at time points of 10 and 21 days, where MURF1 was the only one elevated 
at day 10 and at day 21 both of their mRNA levels were reduced (de Boer et al., 2007a). A 
possible explanation to this could be the timing of muscle sampling failed to coincide with the 
transiently induced response of MAFbx and MuRF1. Thus a comprehensive view of the temporal 
expression of these two ligases especially during the early days into unloading is needed. Despite 
the fact that to date overwhelming studies have examined MAFbx and MuRF1 at the 
transcriptional level there is a general absence of their protein data. Recently two human studies 
have demonstrated that the expression level of MURF1 does not correspond to either condition 
of muscle atrophy or hypertrophy (Leger et al., 2006b, Mascher et al., 2008). Moreover, Leger 
and colleagues have shown increases of the amounts of atrogin-1 mRNA and protein in response 
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to 8 week of resistance training and vice versa during detraining (Leger et al., 2006b). In 
summary, the functional significance of both ligases to the human condition of muscle disuse 
atrophy is yet to be justified. 
 
 
1.5.2 Lysosomal proteolysis 
Lysosomal degradation pathway is another major intracellular proteolytic system in mammalian 
cells. Unlike the well known UPS the role of lysosomal proteolysis in muscle atrophy is only 
beginning to be elucidated. As membrane-bounded vesicles consisting of an acidic lumen that 
encloses high concentrations of hydrolases, lysosomes therefore are organized intracellular 
compartments dedicated to the degradation of a variety of macromolecules. 
Schematically, the activation of lysosomal degradation involves initially the sequestration of 
substrates into vacuoles called autophagosomes. This process of delivering intracellular protein 
substrates to lysosomes is termed autophagy. Substrates are delivered into the lysosomes by 
means of different forms of autophagy known as microautophagy, crinophagy, chaperone-
mediated autophagy or macroautophagy (Blommaart et al., 1997). After autophagosomes fuse 
with lysosomes, lysosomal hydrolases begin to digest the content of vacuoles. Lysosomes are 
well adapted to proteolytic functions in the way that upon delivery of protein substrates for 
degradation the luminal acidic pH and high ratio of cysteine/cystine concentration help to 
weaken their intermolecular charge-charge interactions and promote further breakdown of some 
disulfide bonds. This enables the structurally intact proteins to unfold and so becoming more 
susceptible to proteolysis by lysosomal proteases. The degradation end-products will be 
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selectively delivered to the cytoplasm from lysosomes via membrane transporters where they are 
reused during cellular metabolism.  
The proteolytic capacity of lysosomes is primarily determined by the major lysosomal proteases, 
cathepsins. Cathepsins are a group of enzymes that functions in protein hydrolysis and are 
comprised of endopeptidases (to cleave inner peptide bonds of proteins) and exopeptidases (to 
hydrolyse C-or N-terminal ends). These peptidases can again be categorised into cysteine (there 
are 11 human cysteine cathepsins, i.e., B,C,F,H,K,L,O,S,V,X and W), aspartic (cathepsins D and 
E) and serine (cathepsins A and G) peptidase families (Turk et al., 2012). Cathepsins B, L H and 
D are ubiquitous lysosomal peptidases that are expressed in many tissues. A relatively low 
concentration of cathepsins is present in skeletal muscle compared to other tissues with high 
rates of protein turnover. While within skeletal muscles, slow-twitch oxidative muscles typically 
exhibit higher levels of cathepsins than fast-twitch glycolytic muscles (Bechet et al., 2005). 
Initial morphological indications of the presence of cathepsins within muscle fibers were 
achieved via histochemical and immunohoistochemical investigations, where lysosomal vesicles 
containing immunoreactive cathepsins B and L were observed to present inside myofibres, in 
perinuclear regions beneath the sarcolemma and also found diffusely throughout the sarcoplasm 
(Stauber et al., 1985, Taylor et al., 1987) .Cathepsin B was found to be located in discrete 
vesicles in all muscle types and was more frequently observed at the periphery of the myofibre 
beneath the sarcolemma (Stauber and Ong 1981, Stauber and Ong 1982). 
Although all cathepsins are able to degrade purified myofibrillar proteins the specificity of 
hydrolysis differs from one to another (Katunuma and Kominami 1983, Dufour et al., 1989). 
Whereas cathepsin B hydrolyses myosin heavy chain, troponin T, troponin I and tropomyosin 
(Schwartz and Bird 1977, Noda et al., 1981), cathepsin L degrades the widest range of 
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myofibrillar proteins, including troponin T, I and C, nebulin, titin and tropomyosin, with the 
exception of troponin V (Matsukura et al., 1981). Despite these findings, to date the importance 
of lysosomal proteolysis in muscle atrophy has received little attention since the inhibition of 
lysosomal function with agents that block lysosomal acidification or directly inhibit cathepsins 
has failed to reduce myofibrillar protein content or total protein degradation rate of atrophying 
muscles. However, a current notion suggests that cathepsins do not degrade cytosolic proteins 
like myofibrils but rather their major role is to degrade membrane proteins such as receptors and 
transporters. Evidences have shown that the lysosomal proteolytic pathway functions together 
with ubiquitin-proteasomal pathway to specifically degrade a number of mammalian receptors 
and ion channels. Lysosomal pathway appears likely to contribute to the atrophied muscle 
phenotype. Therefore one would not expect cathepsin inhibition to exert much effect on total or 
myofibrillar protein levels. 
Lysosomal proteolysis has been reported to function in conjunction with other protein 
degradation mechanisms among different models of muscle wasting. With the aid of differential 
display technology and transcriptome analyses overexpression of markers of lysosomal pathway 
have been confirmed to present in various muscle atrophic conditions. Amongst all observations 
of increased capacity for lysosomal proteolysis during muscle atrophy the upregulation of 
cathepsin L expression has been recognized as a general marker (Fujino et al., 2009). A 
systematic induction of cathepsin L mRNA has been observed through transcriptome analyses of 
mRNA contents in atrophying muscles. Other lysosomal cysteine cathepsins are also involved in 
muscle protein degradation such as cathepsin B and D, however their gene expressions are not 
observed in all models of muscle wasting and generally appear less pronounced than those of 
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cathepsin L (Temparis et al., 1994, Bechet et al., 2005). Consequently, these findings support the 
idea that lysosomal degradation is involved in control of muscle mass.  
Review of the literature illustrates that limited information exists regarding the temporal 
implication and myocellular specificity of lysosomal proteolysis in muscle atrophy, which is 
potentially important as slow- and fast-type muscles fibres seem to experience different 
magnitude and time course of atrophy with unloading. Within the available animal unloading 
data, increased cathepsin level and activity have been observed but the vast majority data show 
marked expression of various isoforms of cathepsin mRNAs. Elevated expressions of cathepsins 
L, B and D have all been reported to associate with reduced loading (Taillandier et al., 1996, 
Sacheck et al., 2007). In addition, a very recent study revealed upregulated expressions of many 
lysosomal proteases, lysosomal glucosidases and lysosomal lipases in a tenotomy–induced 
muscle atrophy model (Bialek et al., 2011). However studies suggest that the changes in 
cathepsin mRNA levels do not necessarily indicate similar modifications in lysosomal cathepsin 
activities. This reflects possible control of post-translational sorting of newly synthesized 
cathepsins to endosomes/lysosomes. Other evidences in support of the lysosomal involvement 
include morphological signs. Microscopic studies revealed the presence of secondary lysosomes 
in rat skeletal muscle at 24 and 28 hours of hindlimb suspension (Ferreira et al., 2008). A recent 
experiment using a pan-cathepsin peptide substrate cleavage assay to assess specific cathepsin 
activity in rat muscle has reported an increase in activity from both tenotomy-treated and cast-
immobilized animals (Bialek et al., 2011). 
The research focus on the regulatory networks that control the activation of lysosomal 
proteolytic mechanism in muscle atrophy is at its beginning. In vivo data have identified mTOR 
as regulators of autophagy-related genes via upstream IGF1/Akt signaling or directly by levels of 
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amino acids. Moreover, reduced IGF1/AKT signaling also happens to activate autophagy 
through a mTOR independent mechanism involving FOXO3. Two reports have now 
demonstrated an activation of lysosomal proteolysis by FOXO3 via the transcription of 
autophagy-related genes (Mammucari et al., 2007, Zhao et al., 2007). 
In summary, the lysosomal proteolytic pathway might partially explain the increased protein 
breakdown in animal models of disuse atrophy but its implication in human disuse atrophy is not 
known since there is generally an absence of data.  
 
 
 
 
Figure 1.5 Schematic representation of the major pathways delivering cellular substrates to 
lysosomes. Cytosolic proteins may enter the lysosome by microautophagy (invagination of the 
lysosomal membrane), or by direct transfer through the lysosomal membrane when they contain 
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a KFERQ motif (chaperone-mediated autophagy). Crinophagy targets secreted proteins to 
lysosomes, while membrane lipids and proteins may reach lysosomes by endocytosis. 
Macroautophagy engulfs whole portions of cytoplasm together with various organelles (Bechet 
et al., 2005, Sandri et al., 2013). Abbreviations: Atg 1, autophagy related 1; Atg 5, autophagy 
related 5; Atg 12, autophagy related 12; PAS, phagophore assembly site; LC3, microtubule-
associated protein 1 light chain 3; TGN, trans-Golgi network; LE, late endosome; EE, early 
endosome.  
 
 
1.6 Summary and thesis directions 
In summary of a review of the literature, the typical consequences underlying disuse atrophy 
consist of a shift in the contractile and metabolic phenotype from slow-oxidative toward that of a 
fast-twitch muscle and a reduction of muscle size and volume as a result of a decreased rate of 
protein synthesis and/or increased rate of protein degradation. Among the signaling pathways 
responsible for protein synthesis, costameric protein, focal adhesion kinase (FAK) has been 
recently identified as an upstream element of the mechano-sensory pathway to muscle protein 
synthesis of p70S6K activation, which is Akt-independent (Klossner et al., 2009). Current data 
has supported the idea that during load-dependent muscle remodeling costamere regulation is 
involved. This renders components of costameres potential targets of early modifications to 
reduced load-bearing of skeletal muscle. On the other hand, among the four main mechanisms 
responsible for protein degradation, the ubiquitin proteasome pathway has been recognised as the 
principal regulator of skeletal muscle atrophy. The activity level of chymotrypsin-like enzyme of 
20S proteasome is a direct index of proteolytic activity. To present, the majority of findings on 
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the molecular mechanisms of human disuse atrophy have been reported based on longer periods 
(up to 60 days) of unloading regime (Jones et al., 2004, Ogawa et al., 2006, de Boer et al., 2007b, 
Salanova et al., 2008). The earliest documented molecular adjustments in human skeletal muscle 
with unloading involved pre-translational regulation of protein degradation, protein synthesis and 
mitochondrial metabolism at the transcript level (Chen et al., 2007). No study has yet 
investigated the onset of myocellular adjustments and how those aforementioned markers of 
disuse atrophy might be modified at the protein level early on in unloaded human skeletal muscle. 
In the past few years, components of the ubiquitin-proteasome pathway, especially the E3 
ubiquitin ligases MAFbx and MuRF1, have been suggested to be major regulators of muscle 
mass and promoters of atrophy under muscle wasting conditions including animal models of 
disuse (Foletta et al., 2011). Ubiquitin-proteasome pathways especially MAFbx and MuRF1 
have been extensively studied. Although a consistent elevation of both ubiquitin ligases has been 
observed in animals following various unloading conditions, their increased mRNA level has not 
always been reported in human skeletal muscle in the disuse studies performed to date (Jones et 
al., 2004, Ogawa et al., 2006, de Boer et al., 2007a, Salanova et al., 2008). A number of reports 
have detailed no change or a reduction the mRNA levels of MAFbx or MuRF1. One of the 
explanations for this inconsistency is the lack of a comprehensive examination of the temporal 
expression of these two E3 ligases in response to disuse in humans. A lone report examining 
temporal levels of MAFbx and MuRF1 mRNA has showed 10 days limb immobilization to result 
in elevated mRNA levels for MuRF1 but not MAFbx, however 11 further days of limb 
immobilization saw a subsequent fall in mRNA levels for both E3 ligases (de Boer et al., 2007a). 
As a result, it is currently not possible to determine the functional relevance of MAFbx and 
MuRF1 to the human condition of muscle disuse atrophy.  
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To date the majority of knowledge on the mechanisms underlying disuse induced skeletal muscle 
atrophy has beenobtained from animal studies (Thomason and Booth 1990, Murton et al., 2008).  
As a result, alterations of protein turnover facilitating the loss of muscle mass during disuse in 
humans require to be elucidated. Evidences indicative of a possible contribution of muscle 
protein breakdown in the etiology of human disuse atrophy has been demonstrated (Murton et al., 
2008). Whereas, some reports have suggested the possible mechanism responsible for the 
resulting disuse induced atrophy in humans to involve predominantly depression of muscle 
protein synthesis (Ferrando et al., 1996, Paddon-Jones et al., 2006). Overall, an understanding of 
the regulatory mechanisms behind changes in muscle protein turnover associated with inactivity 
is important in developing effective countermeasures to prevent or attenuate disuse atrophy. 
 
 
1.7 Aims and objectives 
Aim: 
The research aims to improve understanding of the cellular and molecular mechanisms that 
regulate the structural adaptations of skeletal muscle fibres in humans to disuse and to relay it to 
the concurrent functional alterations.  
Objectives: 
 To study the onset of disuse-induced protein level adjustments after 3 days  unilateral 
limb suspension (ULLS) 
 To examine the regulatory mechanisms governing changes in muscle protein turnover 
during the loss of muscle mass following 21 days of unloading  
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 To assess the role of costameres in the regulation of muscle size with altered muscle 
loading. 
Towards this end we applied a number of techniques which are outlined in the following chapter. 
 
 
2. Materials and Methods 
 
 
2.1 Chemicals, Solvents and Reagents 
Sigma (Poole, UK) was the provider of all general chemicals, solvents and reagents unless 
otherwise stated in specific methodology.  
 
 
2.2 MHC II staining 
Frozen slides carrying cryosections of 15 micrometer thickness were thaw for 30 minutes at 
room temperature. Cryosections were fixed for 15 minutes in cold acetone and rinsed three times 
in PBS (8g NaCl, 0.2g KCl, 1.44g Na2PO4, 0.24g KH2PO4 in 1L dH2O at pH 7.4). Peroxidase 
activity was quenched for 10 minutes in 3% H2O2 containing 1ml of 30% H2O2 in 9ml of 
methanol. The sections were then blocked for 30 minutes in a humid chamber with 3% BSA 
consisting of 3g BSA in 100ml PBS. The blocking solution was removed and the sections were 
incubated with primary antibody monoclonal anti-skeletal myosin (fast, MHC II) MY-32 
(M4276 Sigma) at a 1:400 dilution in 0.3% BSA (0.3g BSA in 100ml PBS) for 1 hour. 1ml of 
PBS was added to the slides for 5 minutes then aspirated. This procedure was repeated for four 
51 
 
times. Subsequently, secondary antibody, anti-mouse IgG (FAB specific) peroxidase conjugate 
(A9917 Sigma) was added at a 1:200 dilution in 0.3% BSA for 30 minutes. Again the slides were 
washed four times in 1ml of PBS. Substrate solution was prepared in the dark with a total 
solution of 2ml per slide containing 0.2ml AEC solution (1 AEC tablet (3-amino-9-
ethylcarbazole) dissolved in the dark in 10ml dimethylformamide (DMF), 0.2ml imidazole 
buffer ((17g imidazole, 10.5g citric acid, 14.6g NaCl in 250ml dH2O at pH 7.4), 1.6ml H2O and 
0.4µl H2O2 (30%)). The sections were incubated with the substrate solution in the dark and the 
immunoreactivity was stopped in between 10 to 30 minutes until the fast type fibres were stained 
uniformly and strongly red. The sections were then counterstained with hematoxylin (diluted 
Mayer’s hematoxylin (Merck, Germany) at 1:5 with dH2O) for 10 seconds. Colour was 
developed for 5 minutes in tab water. After that, slides were washed carefully in 80ml PBS-filled 
glass slide holder for 1 minute, then rinsed for another minute with 80ml dH2O and imbedded in 
Aquatex (Merck, Germany). The sections were left to dry overnight, which were then used for 
fibre type percentage and fibre cross-sectional area analysis. 
 
 
2.3 Fibre type percentage and fibre type cross-sectional area analysis 
MHC II stained sections were recorded digitally at 10X magnification on an Axioskop 2 
microscope (Carl Zeiss Ltd, Welwyn Garden City, United Kingdom) using AxioVision software 
(Carl Zeiss Ltd, Welwyn Garden City, United Kingdom). One field from the MHC II stained 
sections was assessed for cross-sectional area of stained (MHC II, fast type) and unstained 
(MHC I, slow type) fibres against a scale by manually recording the fibre periphery of each 
assessed fibre that was operated by the ARDOM software. The recorded cross-sectional area of 
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each fibre has contributed to the calculation of the overall mean cross-sectional area of slow and 
fast fibres by dividing the total area of either fibre type to the total number of that type of fibre 
measured. To obtain the fibre type percentage, either all stained fibres or unstained fibres on the 
section were counted and the following formula was applied.  
       
      No of stained fibres      ×100 
Sum of stained and unstained fibres 
 
 
2.4 Protein isolation and quantification 
Muscle biopsies were cross-sectioned at 25-micrometer using a cryostat. Proteins were isolated 
with rotor stator mixer (ultraturrax, IKA Werke GmbH & Co. KG, Germany) into ice-cold 
modified radioimmunoprecipitation assay buffer (RIPA; 50mM Tris-HCl pH 7.5, 150mM NaCl, 
1mM EDTA, 1% NP-40, 0.25% sodium deoxycholate (90%), 1mM Na3VO4, 1μg/ml leupeptin, 
2μg/ml pepstatin, 1μg/ml aprotinin, 0.1mM PMSF). Muscle protein was quantified with a 
bicinchoninic acid kit (BCA kit) against bovine serum albumin (BSA). 
BCA reagents A and B were purchased from Pierce (Rockford, IL, USA). Reagent B (4% cupric 
sulphate) was mixed thoroughly in a 50ml eppendorf tube with reagent A (sodium carbonate, 
sodium bicarbonate, bicinchoninic acid and sodium tartrate in 0.1M of sodium hydroxide) at a 
ratio of 1:50. Standards made with bovine serum albumin (BSA standards, Pierce) to determine 
the concentration of protein (mg/ml) were prepared with the following composition (see table); 
RIPA (µl) 3 3 3 3 3 3 
Standard BSA 
(µl) 
0 5 10 15 20 25 
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H2O (µl) 47 42 37 32 27 22 
 
Each standard had a total volume of 50µl. Samples were prepared by mixing 3µl protein 
homogenate of each sample thoroughly with 47µl of dH2O. Standard and sample tubes 
containing 50µl solution in total were mixed with 1ml of AB solution, which were then 
incubated at 37ºC for 30 minutes. The optical density of standard or sample solution was 
assessed in cuvettes by UV spectroscopy using a Biotech Photometer (WPA UV1101, Biochrom, 
Cambridge, UK) at 562nm. For the standard curve, the reading was set to zero with 0µl BSA 
(blank-corrected). The protein concentration was estimated against BSA standard curve using 
Excel. The standard curve was generated by plotting the 562nm measurement of each BSA 
standard against its known concentration in mg/ml. Sample concentration was calculated from 
the standard curve.  
 
 
2.5 Immunoblotting   
 
 
2.5.1 Sodium dodecyl sulphate-poly acrylamide gel electrophoresis (SDS-PAGE) 
Gels were prepared using a Mini-Protean III system (Biorad). The kit was assembled according 
to the manufacturer’s instructions. Before pouring the gel the position of the upper level of the 
resolving gel was marked on the glass plate at 1cm below the bottom level of the comb. 7.5% 
resolving gel (7ml dH2O, 3.5ml 1.5M Tris-HCl pH 8.9, 0.1% (w/v) SDS, 3.5ml 30% acrylamide 
1% Bis, 42µl APS (0.046g+460µl dH2O), 14µl TEMED) was poured between the clamped plates. 
0.5ml of dH2O was pipetted over the top of the gel to enable uniform polymerization by 
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preventing air from inhibiting the process at the surface of the gel. The gel was left to polymerize 
for 1 hour. Once polymerized, dH2O was removed and 3% stacking gel (4.5ml dH2O, 1.75ml 
0.5M Tris-HCl pH 6.8, 0.1% (w/v) SDS, 0.7ml 30% acrylamide 1% Bis, 42µl APS 
(0.046g+460µl dH2O), 14µl TEMED) was over-layed. A 10 well-comb was inserted carefully 
into the unpolymerised stacking gel to ensure loading of the sample could take place. The combs 
were lifted evenly once the stacking gel had polymerized and the plates containing the gels were 
assembled in the gel running tank. The upper and lower chambers were filled with 1X running 
buffer (25mM Tris base, 192mM glycine, 2mM EDTA and 0.1% (w/v) SDS in dH2O, pH 9.65). 
The total protein homogenate was denatured in Laemmli buffer (50 mM Tris-HCl pH 6.8, 10% 
glycerol, 2% SDS, 5% 2-mercaptoethanol, 0.01% bromophenol blue) by heating for 5 minutes at 
95°C. 15 micrograms of total muscle protein was loaded per sample lane by using a Hamilton 
syringe. The syringe was rinsed three times in running buffer before loading the next sample. 
Any empty wells were loaded with Laemmli buffer to avoid a discontinuous electric gradient 
across the gel. Molecular weights were determined by the incorporation of 5µl prestained 
molecular weight protein marker to one well per gel. Samples to be resolved were 
electrophoresed at first at 80 volts until samples left the stacking gel then ran the resolving gel at 
120 volts using a Hoefer power supply (Hoefer,Inc., Holliston, MA, USA). The process was 
stopped when the sample buffer tracking dye had left the bottom of the resolving gel. 
Protein quantification by immunoblotting can demonstrate a large inter-assay variability, which 
in my experience mainly comes from inequal development of the luminescent signal during the 
last stage of exposing the labeled membrane. In order to take this into account, samples were 
loaded in a paired manner (i.e. pre, post).  
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2.5.2 Transfer of proteins to hybond-c nitrocellulose 
The glass plates were carefully disassembled without ripping the gels. The stacking gel was 
removed using a scraper. Meanwhile, a piece of Hybond-C nitrocellulose (Amersham Pharmacia 
Biotech, Buckinghamshire, U.K.) and six sheets of Whatman filter paper (Schleicher & Schuell, 
GmbH, Dassel, Germany) were cut to the size of the gel and immersed in transfer buffer 
(114mM glycine, 19mM Tris base, 20% methanol, pH8.3). One layer of foam pre-immersed in 
transfer buffer was placed on the black side of the blotting cassette. Three sheets of pre-
immersed Whatman filter paper were placed on top of the foam, the gel was placed on top of the 
filter paper followed by the Hybond-C nitrocellulose membrane, a further three layers of pre-
immersed Whatman filter paper were placed on top of that and finished with another layer of 
foam. At every stage the layers were rolled with a pipette to ensure no air bubbles were retained 
between layers. The gel sandwich stack held inside the blotting cassette was slided into the 
blotting unit in the chamber with black side (cathode) of the cassette being placed next to the 
cathode side of the unit. The chamber inside an ice filled polystyrene box was filled with more 
transfer buffer and a magnetic stirrer had been added. The proteins were left to transfer onto the 
nitrocellulose membrane overnight using a Hoefer power supply (Hoefer, Inc., Holliston, MA, 
USA).  
 
 
2.5.3 Ponceau S staining 
The transfer efficiency and equal loading of the proteins were validated by staining the 
membrane prior to immunodetection with a non-permanent dye called Ponceau S. Membranes 
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were incubated in 0.1% (w/v) Ponceau S solution with 5% (v/v) acetic acid (28.5ml dH2O, 1.5ml 
acetic acid, 0.033g Ponceau S) for 5 minutes and washed with dH2O to observe. Stained 
membrane was completely destained following washing with 1X TBST (9g NaCl (150mM), 
20ml Tris base (20mM) pH7.5 in dH2O containing 0.5ml Tween 20 (0.05% Tween 20) ). 
 
 
2.5.4 Immunodetection 
The nitrocellulose membrane was blocked in a blocking solution containing 5% dried skimmed 
milk powder (Cadbury’s Marvel Milk Powder, Sainsbury) and 2% BSA (Sigma, Fraction V 
grade) in 1X TBST at room temperature for 1 hour on a rocking platform. Subsequently, the 
membrane was incubated in a primary antibody solution diluted in blocking solution on a 
rocking platform at room temperature for 1 hour. The dilution factor was different according to 
the primary antibody used. Post-incubation, the membrane was washed four times in 1X TBST 
for 5 minutes per wash. The membrane was then agitated in HRP-conjugated secondary antibody 
solution diluted again in blocking solution (according to the primary antibody used) for 30 
minutes. The blot was once again washed four times as described above. All incubations and 
washes were performed in a plastic box on a rocking platform.  
 
 
2.5.5 ECL detection 
Detection of biotin bound proteins was achieved using enhanced chemiluminescence (ECL) with 
an ECL detection kit (SuperSignal West Femto Chemiluminescent Substrate, Pierce, Rockford, 
IL, USA). The ECL substrate was made up from Enhancer solution and Stable Peroxide solution 
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in a ratio of 1:1 (500µl each per membrane), mixed and incubated for 5 minutes with gentle 
agitation according to manufacturer’s instructions. These procedures were performed in the dark. 
Membranes were placed in between plastic sheets and paper towels were used to remove excess 
reaction solution off. The sheets were placed inside the scanning device. Briefly, reagent A 
decays to H2O2, the substrate for peroxidase. Reduction of the enzyme HRP is coupled to a light 
producing reaction by detection with reagent B. This contains lumino, which upon oxidation, 
produces blue light that can be detected on an imaging system. The signal recorded digitally was 
achieved by using the Biorad Imaging System (Hercules, CA,USA) supported by Quantity One 
4.6.2 (Bio-Rad, Hercules, CA,USA).  
 
 
2.6 Proteolytic activity assay 
 
 
2.6.1 Sample preparation 
Homogenates were prepared from 20-micrometer cryosections in 0.1M KH2PO4 buffer (pH7.2) 
containing 2mM EDTA on ice with the help of a Polytron mixer (Kinematica Switzerland) and 
were stored at -80°C. Protein concentration was quantified spectrophotometrically with the 
bicinchoninic acid protein assay kit (Perbio). For the quantification of enzyme activities, all 
samples were adjusted by adding KH2PO4 to achieve a final concentration of 2µg/µl.  
 
 
2.6.2 Chymotrypsin-like protease activity assay  
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The measure of chymotrypsin-like enzyme activity of the 20S proteasome was based on the 
hydrolysis of a fluorogenic substrate essentially as described (Berthon et al 2007). 10µl of 
sample (20 micrograms of muscle extract) was preincubated in 980µl of imidazole buffer (60mM, 
pH 7.4) in pyrex tubes for 5 minutes at room temperature. The reaction was started by the 
addition of 10µl of the 10mM fluorogenic substrate, succinyl-leu-leu-val-tyr-7-amino-4-
methylcoumarin (100μM) (Bachem, I-1395), in the dark to achieve a final reaction volume of 
1ml. Substrate conversion was immediately assessed fluorometrically (excitation at 380nm and 
emission at 460nm) on a SFM25 fluorimeter (Kontron Instruments). All measures were done in 
duplicates, whereby each time four tubes were inserted into positions 1, 2, 3 and 4, and each 
tube’s reading was taken every 15 seconds after the previous tube, in the order in which they 
were placed. Readings were consecutively taken in 1 minute intervals for each tube over the first 
10 minutes of the reaction.  
 
 
2.6.3 Cathepsin B/L activity assay 
For cathepsin B/L activities, methods were used according to those described by (Duguez et al., 
2003). 5µl of sample (10 micrograms of muscle extract) was preincubated in 985µl of sodium 
acetate buffer (100mM sodium acetate, 1mM EDTA, pH 6.0) in pyrex tubes for 5 minutes at 
room temperature. The assay was started by the addition of 10µl of the 10mM 
benzyloxycarbonyl-Phe-Arg-7-amido-4-methylcoumarin (100μM) (Bachem, I-1160) in the dark. 
Then pyrex tubes with 1ml of total solution were immediately placed into a SFM25 fluorimeter 
(Kontron Instruments) and fluorescence was measured at the excitation and emission 
wavelengths of 380nm and 460nm, respectively. Measures on each sample were done in 
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duplicates, therefore, two samples were assessed at a time. Tubes were inserted into positions 1, 
2, 3 and 4 inside the apparatus and each tube’s reading was taken every 15 seconds after the 
previous tube, in the order in which they were positioned. Readings were consecutively taken at 
1 minute intervals for each tube over the first 10 minutes of the reaction.  
 
 
2.6.4 Enzyme activity analysis 
Proteolytic activity was estimated based on a Michaelis-Menten type model of catalytic activity 
where the conversion rate (delta F) (i.e. the increase in fluorometric signal per time) is 
proportional to Vmax. Measures were repeated in 1 minute intervals over the first 10 minutes of 
the reaction and the mean conversion rate was calculated. Since the mean delta F value is in AU 
unit/min, proteolytic activity (Vmax) was calculated by dividing the mean delta F by the gradient 
of the standard curve of 7-amino-4-methylcoumarin drawn from dilutions in the range of 0-150 
pmol/ml.  
To prepare 7-amino-4-methylcoumarin (AMC) standard curve, 7mg AMC was resuspended in 
10ml DMSO to achieve a concentration of 4mM and this stock solution was then diluted 1:400 to 
give 10µM AMC. The table below shows the differential volumes of reaction buffer and AMC 
that were used for the dilution range of 0-150 pmol/ml. The tubes were covered by aluminium 
foil at all times and experiments were performed at room temperature. 
AMC (pmol) 0 30 60 90 130 150 
AMC (10µM) (µl) 0 3 6 9 13 15 
Reaction buffer (µl): 
(imidazole buffer (60mM, pH 7.4) or 
sodium acetate buffer (100mM sodium 
acetate, 1mM EDTA, pH 6.0)) 
1000 997 994 991 987 985 
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For a standard curve every two tubes containing the same amount of AMC were measured at one 
time by SFM25 fluorimeter (Kontron Instruments) at excitation and emission wavelengths of 
380nm and 460nm, respectively. Each time a calibration curve was redone for a new reaction 
buffer that was made. 
 
 
 
V0= Vmax[S] 
        Km+[S] 
 
Figure 2.2 Michaelis Menton equation, which defines algebraically the curve expressing the 
relationship between substrate concentration and reaction rate that has the same general shape for 
most enzymes (a rectangular hyperbola). 
Abbreviation: V0, initial velocity; Vmax, maximum velocity; Km, the Michaelis constant; [s], 
substrate concentration. 
Leonor Michaelis and Maud Menten in 1913 proposed the general theory of enzyme action. 
They postulated that in an enzyme-catalyzed reaction, the enzyme first combines reversibly with 
its substrate to form an enzyme-substrate complex (ES) in a relatively fast reversible step. The 
ES complex then breaks down in a slower second step to yield the free enzyme and reaction 
product, where the rate-limiting step in the reaction is the breakdown of ES complex to the free 
enzyme and product. Therefore the overall rate of an enzymatic reaction is proportional to the 
concentration of the ES complex. The maximum initial rate (Vmax) is observed at high substrate 
concentration when virtually all the enzyme is present as ES and the concentration of E is 
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vanishingly small. Under these conditions, Vmax is directly proportional to enzyme 
concentration. At high [s] the equation simplifies to V0=Vmax (Nelson and Cox 2000). 
 
 
3. Early changes in protein expression in human muscle with unloading are muscle specific 
 
 
3.1 Introduction 
The maintenance of skeletal muscle mass calls for continued mechanical stress (Goldspink et al., 
1995). This load dependence is illustrated by the decrease in size or volume of antigravity 
muscles after unloading induced by real or simulated microgravity (Mayet-Sornay and 
Desplanches., 1996, Ohira et al., 2002). The consequences of unloading are evident at the 
molecular level in human skeletal muscle within 3 days (Gustafsson et al., 2010, Tesch et al., 
2008). Reductions in the MCSA of muscle fibres are detectable within 4-5 days of unloading 
with immobilization (Suetta et al., 2012, Wall et al., 2014). In rodents, atrophy occurs 
concurrently with a shift toward faster fibres type (Desplanches et al., 1987, Fitts et al., 2001). 
Evidence suggets that the reduced energy expenditure associated with chronic unloading is 
accompanied by compromised aerobic capacity and mitochondrial function (Desplanches et al., 
1987, Adams et al., 2003, Flueck et al., 2005). 
The earliest documented molecular adjustments in unloaded human skeletal muscle involve pre-
translational regulation of protein degradation and protein synthesis. For instance, levels of nine 
transcripts involved in control of proteosomal protein degradation (E2 conjugating enzymes, E3 
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ligases, ubiquitin-specific proteases) and inhibition of protein synthesis (4E-BP1) in vastus 
lateralis muscle are increased within 2-3 days of unilateral limb suspension (ULLS) while those 
involved in mitochondrial metabolism are down-regulated (Chen et al., 2007, Gustafsson et al., 
2010, Reich et al., 2010). Also amongst the general lack of changes in content as well as 
phosphorylation state of many measured anabolic signalling factors (AKT, TSC-2, p70S6K, 
4EBP1, eIF4E and eEF2) in the early phase of unloading, there is marked alterations in FAK, 
such that a 30% decrease in FAK phosphorylation and a 20% decrease in content have been 
reported after 10 days of ULLS (Goldspink et al., 1995, Rennie et al., 2010). FAK 
phosphorylation at tyrosine residue Y397 have been demonstrated to regulate myofibrillar 
protein synthesis as well as the slow-oxidative expression program in a load-dependent fashion 
(Durieux et al., 2009). Phosphorylation of Y397 enables FAK to develop its full catalytic 
activity, phosphorylate auxiliary sites (e.g. Tyr576/577) and enter interactions with further 
binding partners (Schlaepfer et al., 1999). pY397 FAK has also been shown to play important 
roles in the assembly and the turnover of focal adhesions that connect the cytoskeleton in the cell 
interior to the extracellular matrix and responsible for mechano-sensing in a number of cell types 
(Bershadsky et al., 2003, Schlaepfer et al., 2004, Grounds et al., 2005, Chiquet et al., 2009). 
Focal adhesion complexes of the sarcolemma (costameres) (Huijing 1999, Ervasti et al., 2003, 
Grounds et al., 2005, Quach et al., 2006) are targets of early modifications with reduced load 
bearing of skeletal muscle (Rybakova et al., 2000, Anastasi et al., 2008). Studies have 
demonstrated that the concentrations of the costamere components paxillin and meta-vinculin are 
altered in rodent skeletal muscle following 7 days of unloading (Gordon et al., 2001, Chopard et 
al., 2002). These observations coincide with changes in the amount and activation status (Gordon 
et al., 2001, de Boer et al., 2007a) of FAK. Interestingly, the unloading induced concentration 
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changes of costamere components in rat happen to differ between muscles types according to 
their initial fibre type composition. Such that within one week of unloading paxillin and FAK are 
reduced in mixed and fast type muscles, m. plantaris and m. gastrocnemius, but the opposite is 
true in the slow soleus muscle (Gordon et al., 2001). Moreover, meta-vinculin concentration is 
increased after 3 weeks of unloading in slow type muscle but decreased in fast type muscle 
(Chopard et al., 2002). Similarly, the concentration of meta-vinculin is known to increase in 
soleus but not in vastus lateralis muscle after 56 days of bedrest (Chopard et al., 2005), which 
mirrors the differential modulation of the expression of proteolysis-related gene transcripts, in  
slow-type compared with mixed-type muscles after 3 days of unloading (Goldspink et al., 1995). 
In light of these results, the possible relation between muscle-specific costameric remodelling 
and factors that set the slow-oxidative phenotype during slow-to-fast fiber transformation 
induced by muscle unloading should be investigated. 
In a skeletal muscle, the expressions of mitochondrial and contractile proteins can be correlated 
to the fractional synthesis rates of these proteins (Adey et al., 2000, Lopes et al., 2006). During 
unloading, there is a decrement in both mitochondrial and slow type myosin contents 
(Desplanches et al., 1987, Ferretti et al., 1997), indicating that underlying proteins are targeted 
for proteolytic degradation. The diminished drive for the maintenance of a slow-oxidative 
phenotype of anti-gravity muscle with unloading is corroborated by a correlated down-regulation 
of respiratory chain constituents in rat soleus muscle (Flueck et al., 2005). Such findings suggest 
that the correlation pattern between mitochondrial, contractile and proteolytic elements is likely 
to be modified during muscle unloading. 
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3.1.1 Hypothesis 
In the current study, we investigated whether 3 days of unloading initiated fibre transformation at 
the protein level. We hypothesized that human anti-gravity muscles would undergo fast muscle 
remodelling in response to unloading by unilateral limb suspension (ULLS), and that this could 
be detected within three days of the start of the unloading phase. Specifically, we hypothesised 
that this fast muscle remodelling would involve altered expression of costamere components, 
which are related to mechanosensory muscle remodelling via the organization of the attachment 
of muscle organelles and gene expression (Grounds et al., 2005, Quach and Rando 2006, 
Klossner et al., 2013), factors of the mitochondrial respiratory chain and the slow type myosin 
heavy chain. We further speculated that these responses would differ between the phenotypically 
distinct leg muscles, m. vastus lateralis and m. soleus. and would reflect differences in the 
activity of chymotrypsin, a main contributor to the 20S proteasome, being increased within 5 
days of unloading in the rat (Berthon et al., 2007), and/or expression of costameric proteins. 
Subsequently, we assessed whether quantitative, linear relationships existed between unloading 
induced changes in chymotrypsin activity and fibre MCSA and between the levels of selected 
proteins that define the slow oxidative muscle phenotype and whose expression is subject to 
regulation by FAK protein and its pY397 content (Durieux et al., 2009, Klossner et al., 2013).  
 
 
3.2 Methods 
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3.2.1 Subjects  
Healthy men (mean ± SD; 25 ± 5 yr, 183 ± 3 cm, 76 ± 8 kg) were recruited from the 
metropolitan area of Stockholm. The subject sample ranged from physically active to sedentary 
individuals. Subjects were screened for any history of lower limb pathology, neuromuscular 
disorder, or cardiovascular disease. Written consent was obtained from each subject after being 
informed of the procedures, risks, and potential benefits associated with the experiments. The 
study protocol was approved by the Ethics Committee at the Karolinska Institutet and conducted 
in accordance with the Declaration of Helsinki (1964).  
 
 
3.2.2 Unloading  
Unilateral limb suspension (ULLS) was accomplished as previously described (Tesch et al., 
2008, Gustafsson et al., 2010). In brief, upright or ambulatory activities were aided by short-
length crutches with handgrip and forearm support distal to the elbow (Swereco Rehab AB, 
Sollentuna, Sweden). The right foot was equipped with a shoe outfitted with a 10 cm thick sole 
in order to remove weight-bearing load from the left unloaded limb. There were no straps 
attached to the shoe restraining ankle- or knee-joint movement. The subjects lived at home and 
maintained their normal occupational tasks throughout the experimental period. Compliance was 
encouraged through daily interaction with one of the investigators. Two weeks prior to the ULLS 
intervention, all subjects underwent four sessions to practice walking on crutches and daily tasks 
associated with the ULLS intervention. The subjects refrained from any strenuous physical 
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activity three days prior to the onset of ULLS yet maintained their normal dietary habits. To 
assure compliance, all subjects were interviewed daily via telephone or in person.  
 
 
3.2.3 Collection of muscle samples  
Muscle biopsies were obtained from the right leg prior to ULLS and from the left leg after 
completing 72 hrs of ULLS and before resuming any weight-bearing activity. Following an 
overnight fast and after injection of local anaesthetic (Carbocain®) and skin incision, biopsies 
were obtained from vastus lateralis and soleus muscle using a 5 mm Bergström needle. Samples 
were cleansed of excess blood, connective tissue, and fat and then frozen in liquid nitrogen and 
stored at -80°C until further analysis. 
 
 
3.2.4 Immunoblotting  
Muscle biopsies were cross-sectioned at 25 micrometers using a cryostat; proteins were isolated 
with rotor stator mixer (ultraturrax, IKA Werke GmbH & Co. KG, Germany) into ice-cold 
modified radio immunoprecipitation buffer (RIPA; 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 
mM EDTA, 1% NP-40, 0.25% sodium deoxycholate at 90%, 1 mM Na3VO4, 1 μg/ml leupeptin, 
2 μg/ml pepstatin, 1 μg/ml aprotinin, and 0.1 mM PMSF; Sigma, Buchs, Switzerland). Muscle 
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protein was quantified with a bicinchoninic acid kit (Pierce) against bovine serum albumine 
(BSA). Total protein was denatured in Laemmli buffer (50 mM Tris-HCl, pH 6.8, 10% glycerol, 
2% SDS, 2%-mercaptoethanol, and 0.1% bromphenol blue) by heating for 5 min at 95°C. Equal 
amounts of total muscle protein per lane (i.e. 20 micrograms) were resolved via 7.5% sodium 
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) using a Mini-Protean III 
system (Biorad). The loading was in a paired design with four pre-/post-ULLS samples from 
SOL or VL muscle of subjects per gel loaded in adjacent lanes. Proteins were blotted onto 
nitrocellulose membrane (Amersham) and blotting efficiency and equal loading were verified by 
Ponceau S staining. Membranes were subjected to immunodetection with specific first antibodies 
and horseradish peroxidase-(HRP)-coupled secondary antibodies. For the detection of FAK-
related proteins, this involved the polyclonal C-terminal antibody from animal "Lulu" as 
published (Flueck et al., 1999) and anti-rabbit HRP antibody (ICN Biomedicals GMBH, 
Germany). For vinculin this included a described monoclonal antibody (Goldspink et al., 1995) 
and anti-mouse HRP antibody (ICN). For detection of the mitochondrial proteins succinate 
dehydrogenase complex, subunit A (SDHA); ATP synthase, H+ transporting, mitochondrial F1 
complex, alpha subunit 1 (ATP5A1); ubiquinol-cytochrome c reductase core protein I 
(UQCRC1) and NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9 (NDUFA9), an 
antibody mix (Molecular Probes/Invitrogen Ltd, Paisley, UK) was used. For the detection of 
slow-type myosin heavy chain, MHCI, a monoclonal antibody (Sigma Chemicals, Buchs, 
Switzerland), and anti-mouse HRP antibody (ICN Biomedicals GMBH, Germany) were used. 
Signal detection was carried out with enhanced chemiluminescence (Femto kit, Pierce) and 
quantified with a Chemidoc system running under Quantity One software (Bio-Rad, Life Science 
Research, Hercules, CA, USA). The signal intensity of the respective band was estimated with 
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the "volume rectangular tool" and corrected versus the background of a band of equal height and 
size (area) in an empty sample lane. Background-corrected data were normalized to the mean 
values of the pre-ULLS samples for the respective gel; the values therefore reflect relative 
expression levels per total muscle protein. In addition, blots combining sample pairs from soleus 
(SOL) and vastua lateralis (VL) muscle were run on the same gel to compare and adjust relative 
protein content between the two muscle groups.  
The content of FAK-pY397 per total protein was assessed as described (Klossner et al., 2009). In 
brief, the soluble fraction of 500 micrograms of total protein in 1 ml RIPA buffer was subjected 
to immunoprecipitation over night with 1 mg FAK-pY397-specific antibody (Invitrogen) and 50 
microliters of a 10% slurry of protein A Sepharose (Sigma) at 4°C under continuous rotation 
using an Intellimixer (Progen Scientific). The precipitate of a 2-minute spin at 5000 g at 4°C was 
washed twice with 500- microliter RIPA, separated by 7.5% SDS-PAGE, western blotted onto 
nitrocellulose, and divided into two parts at the height of 85 kDa before being subjected to 
immunodetection with FAK-specific antibody as described above. 
 
 
3.2.5 Proteosomal activity 
Homogenates were prepared from 20-micrometer cryosections in 0.1 M KH2PO4 buffer (pH7.2) 
containing 2 mM EDTA on ice with the help of a polytron mixer (Kinematica, Switzerland). 
Protein concentration was quantified spectrophotometrically with the bicinchoninic acid protein 
assay kit (Perbio) and adjusted to 2 mg/ml. Samples were distributed in aliquots and stored at -
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80°C. The quantification of chymotrypsin-like enzyme activity of the 20S proteasome, 
representing the catalytic core of the proteasome, was based on the hydrolysis of a fluorogenic 
substrate essentially as described (Berthon et al., 2007). In brief, 20 micrograms of muscle 
extract were incubated in a final volume of 1 ml imidazole buffer (60 mM; pH 7.4). The reaction 
was started by the addition of 100 μM of the fluorogenic substrate succinyl-leu-leu-val-tyr-7-
amido-4-methylcoumarin (Bachem, I-1395). Substrate conversion was assessed fluorometrically 
(excitation at 380nm and emission at 460nm) on a SFM25 fluorometer (Kontron Instruments). 
Proteolytic activity was estimated based on a Michaelis Menten type model of catalytic activity 
where the conversion rate (i.e., the increase in fluorometric signal per time) is proportional to 
Vmax. Measures were repeated in minute intervals over the first 10 minutes of the reaction and 
the mean conversion rate calculated. Proteolytic activity (i.e., Vmax) was then calculated versus 
standard curve of amido-4-methylcoumarin drawn from dilutions in the range of 0-150 pmol/ml. 
 
 
3.2.6 Fibre-type percentage and fibre type cross-sectional area analysis 
15-micrometer cryosections of VL and SOL muscle were incubated with a 1:400 dilution of 
mouse monoclonal antibody against fast myosin heavy chain (Clone MY-32, Sigma-aldrich) in 
0.3% BSA in phosphate buffered saline (PBS), then reacted with a 1:2000 dilution of horseradish 
peroxidase -conjugated anti-mouse IgG (ICN). Immunoreactivity was detected with substrate 
solution, 3-amino-9-ethylcarbazole in dimethylformamide (Sigma Chemicals, Buchs, 
Switzerland). Nuclei were counterstained with hematoxylin and embedded in Aquatex (Merck, 
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Germany). Sections were then processed to assess fibre-type composition and cross-sectional 
area of slow- and fast-type fibres. 
Myosin heavy chain-stained sections were recorded digitally at 10x magnification on Axioskop 2 
microscope (Carl Zeiss Ltd, Welwyn Garden City, United Kingdom) that was operated with 
AxioVision software (Carl Zeiss Ltd, Welwyn Garden City, United Kingdom). Subsequently, 
one field from fast-type myosin heavy chain-stained sections was assessed for cross-sectional 
area of stained (fast-type) and unstained (slow-type) fibres against a scale by manually recording 
the periphery of each assessed fibre within the ARDOM software (Flueck et al., 2011). This 
differentiation was based on the observation that the large majority of muscle fibres in human 
vastus lateralis musle are pure type I or type II fibres (Flueck et al., 2011). These numbers were 
used to calculate the percentage and mean cross-sectional area of slow- and fast-type muscle 
fibres. The area content of slow-type fibres was calculated using the formula [area content of 
slow-type fibre percentage of slow-type fibres x mean cross-sectional area of slow-type 
fibers/100%]. On average, 159 slow- and 36 fast-type muscle fibres were counted per muscle 
cross section of SOL and an average of 88 slow- and 87 fast-type muscle fibres were counted per 
muscle cross sectionof VL. 
 
 
3.2.7 Statistical analysis  
Post vs. pre changes and interaction effects of muscle type (SOL, VL) were assessed with a 
repeated-measures ANOVA with as within factor time (pre/post). In the case of interactions, 
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differences were localized with the post hoc test of Fisher or Wilcoxon signed rank test, 
dependent on whether the data were normally distributed or not, respectively (Statistica 9.1). The 
differences were visualized as the delta between post vs. pre values. The post-hoc test was 
relaxed to a one-tailed test in cases where a single-sided hypothesis could be formulated, i.e. the 
increase in meta-vinculin (Adams et al., 2003) and mitochondrial protein (Quach and Rando, 
2006). Effects with p-values p< 0.05 were considered significant and 0.05 ≤ p < 0.10 were 
viewed as a trend. All correlations of normalised values were calculated using Statistica 9.1 
using Pearson correlations and displayed as correlation matrices (p-value weighted).  
Pearson correlations, visualized with Cluster and Tree and exported into Powerpoint (MS-Office) 
as described (Bey et al., 2003). For both SOL and VL n=8 pre and n=8 post, with the only 
exception for mitochondrial protein expressions in VL where n=7. 
 
 
3.3 Results 
 
 
3.3.1 Muscle specific fibre type composition  
The soleus muscle had 32% more type I fibres than the m. vastus lateralis before ULLS 
(p=0.0045, ANOVA with post-hoc test of Fisher; Fig. 3.1). Type II fibres showed a trend for 
increased mean cross sectional area (MCSA) compared to type I fibres in both VL (p=0.09) and 
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SOL (p=0.09). MCSA of type I and II fibres in m. vastus lateralis and m. soleus was not altered 
post 3 days ULLS (Table 3.1).  
 
Figure 3.1 Microscopic pictures of muscle cross sections of VL and SOL pre and post ULLS 
after staining for type II myosin type heavy chain (orange). Nuclei appear in blue.  
                                                    
 
 
                                                          pre      post   
m. vastus lateralis 
 slow type: 5275 ± 442 4446 ± 581  
 fast type: 6225 ± 292 5180 ± 540  
 
 
73 
 
 slow type% 51 ± 7% 43 ± 6% 
 
m. soleus    
 slow type: 6330 ± 479 5728 ± 452  
 fast type: 7352 ± 382 6889 ± 943  
 slow type% 86 ± 4% 97 ± 4% 
 
 
Table 3.1 Mean and standard error of the mean of the fibre cross sectional area of slow and fast 
type muscle fibres, and the percentage of slow type muscle fibres in the two studied anti-gravity 
muscles pre and post 3 days of ULLS. No significant difference was identified (two tailed 
Fisher-test). 
 
 
3.3.2 Changes in protein expression after 3 days unloading  
FAK-pY397 content per total protein was 20% reduced in VL but not altered in SOL (Fig. 3.2). 
Figure 3.3 shows representative immunoblots of the detected mitochondrial, costameric and 
sarcomeric proteins (MHC1). For individual proteins, an increased content of meta-vinculin was 
apparent in m. soleus after 3 days of ULLS (p=0.03), but not in m. vastus lateralis (p=0.23; Fig. 
3.4). There was also a trend (p=0.059) for an elevation of combined mitochondrial protein 
content in m. vastus lateralis. 
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Figure 3.2 A) Top, example of immunoprecipitated FAK-pY397 from total homogenate of VL 
and SOL pre and post ULLS for two subjects. The position of FAK-pY3967 is indicated. Bottom, 
the amount of immunoglobulin/protein is shown as a loading control in the panel below. B) Bar 
graph showing mean and standard error of FAK-pY397 levels in SOL and VL pre and post 3 
days of ULLS. * denotes p < 0.05 (one-tailed Wilcoxon-test). 
A) 
B) 
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Figure 3.3 Representative immunoblots visualizing the detected proteins in m. soleus and m. 
vastus lateralis. 
MHC I 
76 
 
 
Figure 3.4 Mean and standard error of protein level changes with 3 days of ULLS in VL and 
SOL. Asterisk indicates those gene ontologies and proteins which were significantly affected by 
ULLS. *denotes p< 0.05 (Fisher test).  
 
 
3.3.3 Proteosomal activity 
We followed the activity of chymotrypsin, as this enzyme is a major component of the ubiquitin-
proteasome pathway, which is mainly responsible for the degradation of sarcomeric proteins 
seen in unloading (Ikemoto et al., 2001, Capetanaki 2002, Schlaepfer et al., 2004, Polge et al., 
2011). Chymotrypsin activity in m. vastus lateralis was not altered after 3 days of ULLS (p=0.72) 
nor was its activity changed in m. soleus (p=0.85). 
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3.3.4 Changes in various protein components were associated with changes in 
chymotrypsin activity  
Fold changes in chymotrypsin activity correlated negatively with fold changes in ATP5A1 (r=-
0.80, p=0.02) in the VL but not in the SOL. No other significant correlations were found: 
UQCRC1 (r=-0.61, p=0.10), NDUFA9 (r=-0.78, p=0.22) and the area content of slow type fibres 
(r=-0.65, p=0.08) in VL.  
 
 
3.3.5 Deregulated coordination of expression  
Muscle specific changes with unloading were also reflected by modified linear relationships 
between proteins that define the slow oxidative muscle phenotype. At a threshold of r ≥ 0.70 and 
p<0.05 this concerned a loss of positive correlations in SOL after 3 days of ULLS between 
respiratory chain constituents SDHA, ATP5A1 and UQCRC1 and slow myosin heavy chain 
(MHC1). Similarly, negative correlations between mitochondrial proteins and FAK-pY397 were 
lost while positive correlations developed respectively to FAK and FRNK after unloading.  
In the VL, unloading affected correlations between mitochondria factors and structural 
components of costameres. After ULLS, negative correlations appeared between the vinculin 
isoforms and mitochondrial proteins. FAK-pY397 positively correlated with FAK/FRNK. 
Moreover, the positive linear relationship observed between FAK-pY397 and MHC1 prior to 
ULLS was inverted (Fig. 3.5). 
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p-value weighed 
r-value   
 
 
Figure 3.5 Correlation matrices visualizing the changes in linear relationships in the studied 
muscles with 3 days of ULLS. Transitions can be visualized by comparing relationships pre vs. 
post ULLS along the symmetry axes. Circles denote relationships of interest. R-values are given 
in colour coded boxes.  
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3.4 Discussion 
 
 
3.4.1 Protein and fibre size alterations do not reach significance after 3 days of ULLS 
Reduced weight bearing induces muscles loss mainly by decreasing anabolic drive because of 
decrased protein synthesis and increased proteolysis (Ohira et al., 2002). The consequences of 
unloading are evident at the molecular level in rodent and human anti-gravity muscles within the 
early days of unloading. (Bershadsky et al., 2003, Berthon et al., 2007). The quantitative 
importance of modified gene expression for the early structural changes in human muscle fibres 
that lead to atrophy is not fully understood (Adams et al., 2003, Schlaepfer et al., 2004). Our 
investigation is the first to corroborate the notion of early molecular changes at the protein level 
after discontinued weight bearing in human antigravity muscles. The study demonstrated a 
muscle-specific transition in the correlation pattern of factors that reflect the slow oxidative 
phenotype and a reduced activity status of FAK (Fig. 3.2). Consistent with the previously 
reported time pattern of  muscle loss after reduced weight bearing (LeBlanc et al., 1995), we did 
not find significant alterations in MCSA of muscle fibre types after 3 days of ULLS (Table 3.1).  
 
 
3.4.2 Relationship between mitochondrial proteins and slow myosin heavy chain  
The validity of assessing expressional changes by correlation analysis is supported by the linear 
relationships in the slow soleus muscle. For the soleus muscles of our subjects, which contained 
32% more slow fibres than the m.vastus lateralis, significant correlations were identified 
between the protein content of slow myosin heavy chain and mitochondrial proteins (SDHA, 
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ATP5A1, and UQCRC1; r<0.7, p<0.05). It has previously been reported that mitochondrial 
respiratory chain components exist in equal proportion (Lopes et al., 2006) and that fractional 
synthesis rates of myosin heavy chain and mitochondrial protein are correlated (Adey et al., 
2000). However, a correlation between mitochondrial proteins-and slow myosin heavy chain in 
human tissue has to the best of our knowledge not been reported before. 
 
 
3.4.3 Ubiquitin-proteasomal-mediated proteolysis and fibre type transformation  
Despite an absence of significant post vs. pre chymotrypsin-like enzyme activity changes, there 
was a reduction in the area content of slow type fibres. This change, and that in the expression of 
two mitochondrial proteins (ie. ATP5A1, UQCRC1), tended to be correlated negatively with fold 
changes in chymotrypsin activity only in the vastus lateralis (r>0.6, p≤ 0.10). This latter enzyme 
constitutes a main component of the proteasome machinery for muscle atrophy (LeBlanc et al., 
1995, Gustafsson et al., 2010). Such observation mirror the more pronounced upregulation of 
mRNAs for atrogin-1 and MuRF-1 in m.vastus lateralis compared to m.soleus after 3 days 
unloading during a recent human study (Goldspink et al., 1995).  
 
 
3.4.4 Correlations between the slow oxidative characteristics of fibre types in unloading 
Changes in metabolic and contractile composition of muscle fibres have been seen after 2 weeks 
of simulated microgravity in rats and humans (Desplanches et al., 1987, Chopard et al., 2005). In 
this study, there was a loss of correlation between slow myosin heavy chain and mitochondrial 
protein (SDHA, ATP5A1, and UQCRC1) levels in the slow soleus muscle following ULLS. 
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Moreover, there was a trend for an increased expression of meta-vinculin post ULLS that has 
been suggested to indicate slow-to-fast fibre transformation (Bey et al., 2003). Such a selective 
increase in metavinculin in the predominantly slow type soleus but not the mixed vastus lateralis 
after 3 days of ULLS corresponds to a previous finding on the effect of 84 days of bedrest (Bey 
et al., 2003). Overall, the above mentioned observations support the notion of elevated 
metavinculin content being an early muscle-specific marker of the phenotypic response to 
unloading (ie. a slow-to-fast fibre type transformation), prior to significant changes in MCSA.  
Despite down-regulated phosphorylation of the auto-regulatory site Y397 of FAK, FAK protein 
content was not affected during early unloading. Interestingly FAK-pY397 content was only 
reduced in vastus lateralis muscle (Fig. 3.2), corresponding with the larger degree of molecular 
alterations seen in this muscle than in soleus muscle (Goldspink et al., 1995). Mechano-regulated 
Y397 phosphorylation of FAK has also been shown to lie upstream of the regulation of ribosome 
biogenesis by p70S6K which is essential for regulation of muscle mass (Huijing 1999).  
 
 
3.5 Conclusions  
First signs of fibre transformation might be observed in human anti-gravity muscle after 3 days 
of unloading as shown by an increase in meta-vinculin level and a loss of significant positive 
correlations between markers of the slow, oxidative phenotype in a slow-type muscle.  
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4. Effects of 21 days unloading on the regulation of anabolic and catabolic signaling in 
human vastus lateralis muscle 
 
 
4.1 Introduction  
A loss of muscle mass in response to actual and simulated microgravity exposure has been well 
documented (Tsika et al., 1987, Fitts et al., 2000, Ohira et al., 2002, Adams et al., 2003, Jones et 
al., 2004, de Boer et al., 2007a). In general, a reduction in muscle mass is the result of either a 
decreased rate of protein synthesis and/or increased rate of protein degradation (Judge et al., 
2007, Fujino et al., 2009, Marimuthu et al., 2010). To date, the majority of knowledge of the 
regulatory mechanisms underlying muscle disuse atrophy has been generated from animal-based 
approaches (Thomason and Booth 1990, Murton et al., 2008). As a result, the facilitative change 
causing the loss of muscle mass with disuse in humans still need to be fully elucidated. 
Observations of increased amounts of ubiquitin-protein conjugates and 3-methylhistidine suggest 
a possible contribution of muscle protein breakdown in the etiology of human disuse atrophy. On 
the other hand, others have speculated that the decline in muscle protein synthesis is the 
mechanism solely responsible for disuse induced atrophy in humans (Ferrando et al., 1996, 
Paddon-Jones et al., 2006). 
Among the anabolic mechanisms, the Akt/mTOR signaling cascade has been considered to date 
as the most well documented molecular pathway responsible for protein synthesis. Experimental 
evidence suggests that mechanical stimuli can lead to increased protein synthesis via two initial 
triggers, increased growth factor concentration or direct mechanical tension. Akt/mTOR 
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signaling happens to integrate the growth factor-dependent control of muscle mass, whereas the 
latter form of stimulation has not been well characterized. It is now widely recognized that there 
is a mechano-dependent signalling pathway to modulate protein synthesis in load-dependent 
skeletal muscle remodelling. Evidence currently sheds light through muscle-targeted transgenesis 
in a rat hindlimb unloading and reloading model, identifying focal adhesion kinase (FAK) as an 
upstream element of a mechano-sensory pathway to muscle protein synthesis of p70S6K 
activation, which is Akt-mTOR independent (Klossner et al., 2009). Further attention is needed 
to assess whether this pathway is responsible for eliciting the observed decline in muscle protein 
synthesis following human skeletal muscle disuse. 
For potential mechanisms regulating protein degradation, an animal unloading study has 
demonstrated that a reduction in muscle mass is accompanied by increased expression of 
components within the lysosomal and ubiquitin-proteasomal systems (Ferreira et al., 2009). The 
fact that inhibitors of lysosomal function fail to block the degradation of myofibrillar 
components in atrophying muscles has resulted in limited data available on lysosomal 
contributions to muscle atrophy. However, an increased capacity for lysosomal proteolysis has 
been demonstrated in these data from animal models of various types of atrophy, including 
disuse atrophy. The role of lysosomal proteolytic pathway in disuse atrophy is underlined by 
recent investigations on cathepsin expression, where cathepsin L and cathpesin B genes appear 
upregulated (Bechet et al., 2005). Since variations in cathepsin mRNA levels are not 
systematically correlated with similar modifications in cathepsin activities (Bechet et al., 2005), 
the need to measure the actual activity of cathepsin isoforms warrants attention. Currently, data 
have shown that the major function of lysosomes is to degrade membrane proteins rather than 
cytosolic proteins like myofibrils. Therefore, one would not expect their inhibition to have much 
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effect on myofibrillar protein and total protein degradation rates. In fact, in vivo data has shown 
that lysosomal and ubquitin-proteasomal pathways operate in conjunction to degrade specific 
membrane protein substrates such as receptors and ion channels (Bechet et al., 2005, Zhao et al., 
2007). Thus, it is necessary to examine the involvement of the lysosomal pathway in human 
disuse atrophy.  
In contrast to a limited data available on lysosomal involvement in disuse atrophy, ubquitin-
proteasome pathway has been extensively studied. As a result, a substantial body of evidence 
implicates UPS to be the principle regulator of skeletal muscle atrophy. Numerous studies 
carried out on differing models of human muscle disuse atrophy have focused their attention on 
two muscle-specific Ub-ligases, MuRF1 and MAFbx. Contrary to a classical elevation of 
MuRF1 and MAFbx mRNA in animal models of disuse, the human data is inconsistent. Due to a 
general absence of protein measurements for these two E3-ligases, and the lack of assessments 
on other representative elements of the UPS, it is currently difficult to discern the actual 
importance of UPS in the human conditions of muscle disuse atrophy.  
 
 
4.1.1 Aim and hypothesis  
Our aim was to investigate the selected mechanisms implicated in the loss of muscle mass after a 
chronic unloading period of 21 days in humans. In order to obtain more information on the 
effects of disuse in the context of likely decreases in muscle protein synthesis as well as possible 
increases in muscle protein degradation, we examined muscle fibre morphology and potential 
factors associated with anabolic signalling (ie. protein content of FAK and p70S6K), and 
markers representative of the catabolic pathways (ie. cathepsin B/L enzyme activities, 
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chymotrypsin-like enzyme activity) in response to disuse. We hypothesized that total protein 
levels of these anabolic signalling molecules might change to a state to reflect reduced 
translational capacity, while the catabolic enzyme activity levels would increase in association 
with elevated proteolytic capacity.  
 
 
4.2 Methods 
 
 
4.2.1 Subjects  
Nine healthy adult men were recruited from the Manchester area. The subject sample ranged 
from physically active to sedentary individuals. Prior to the experiments, participants were 
screened for any history of lower limb pathology, neuromuscular disorder or cardiovascular 
disease. Written consent was obtained from each participant after being informed of the 
procedures, risks and potential benefits associated with the experiments. The study protocol was 
approved by the Ethics Committee at Manchester Metropolitan University. 
 
 
4.2.2 Induction of atrophy  
Unilateral limb suspension (ULLS) was accomplished as previously described (de Boer et al., 
2007a). Prior to the ULLS intervention, all participants took time to practise walking on crutches. 
In brief, the non-dominant leg of each participant was fitted with a platform shoe and the domain 
leg was kept in a slightly flexed position using straps suspending the foot above the ground while 
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walking with crutches. The participants had to walk on crutches for the whole duration of the 21-
day suspension period. They were asked to refrain from loading the leg in any way, including by 
driving vehicles, yet maintained their normal dietary habits and their normal occupational tasks 
throughout the experimental period.  
 
 
4.2.3 Collection of muscle samples 
Biopsies (50mg) of vastus lateralis muscle were taken prior to ULLS and after 21 days of ULLS 
before resuming any weight-bearing activity by use of the Bergström technique (Mayet-Sornay 
and Desplanches 1996). After making skin and fascia incisions under local anaesthesia (1% 
lignocaine), muscle biopsies were obtained from the m.vastus lateralis using a 5 mm Bergström 
needle. Muscle samples were cleansed of excess blood, connective tissue and fat, and then frozen 
in liquid nitrogen and stored at -80°C until further analysis. 
 
 
4.2.4 Immunoblotting  
Muscle biopsies were cross sectioned at 25 micrometers using a cryostat, proteins were isolated 
with rotor stator mixer (Ultra-Turrax, IKA Werke GmbH & Co. KG, Germany) into ice-cold 
modified radio immuno precipitation buffer (RIPA; 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 
mM EDTA, 1% NP-40, 0.25% sodium deoxycholate at 90%, 1 mM Na3VO4, 1 μg/ml leupeptin, 
2 μg/ml pepstatin, 1 μg/ml aprotinin, and 0.1 mM PMSF; Sigma, Buchs, Switzerland), where an 
amount of 10 mm3 tissue corresponding to 2 mg of protein was pooled and mixed in 200 µl RIPA 
buffer. Muscle protein was quantified with a bicinchoninic acid kit (Pierce) against bovine serum 
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albumine (BSA). Total protein homogenate of a 2 mg/ml concentration was denatured in 
Laemmli buffer (50mM Tris-HCl pH 6.8, 10% glycerol, 2% SDS, 2%-mercaptoethanol, 0.1% 
bromphenol blue) by heating for 5 minutes at 95°C. 20 micrograms of total muscle protein per 
sample lane were separated using 7.5% sodium dodecyl sulphate-poly acrylamide gel 
electrophoresis (SDS-PAGE) using a Mini-Protean III system (Biorad). Proteins were blotted 
onto nitrocellulose membrane (Amersham) and blotting efficiency and equal loading were 
verified by Ponceau S staining. Membranes were then incubated in 5% low fat milk in TBS with 
0.1% tween. Subsequently, membranes were subjected to immunodetection with specific first 
antibodies and horseradish peroxidase (HRP)-coupled secondary antibodies. For the detection of 
FAK this involved polyclonal C-terminal antibody ‘Lulu’ and anti-rabbit HRP antibody (ICN 
Biomedicals GMBH, Germany). As for the detection of p70S6K this included polyclonal 
antibody p70S6K (C-18) (Santa Cruz, USA) and anti-rabbit HRP antibody (Santa Cruz, USA).  
Signal detection was carried out with enhanced chemoluminescence (Femto kit, Pierce) and 
quantified with a Chemidoc system running under Quantity One software (Bio-Rad, Life Science 
Research, Hercules, CA, USA). The signal intensity of relevant bands was estimated with the 
‘volume rectangular tool’ and corrected versus the background of a band of equal height and size 
(area) in an empty sample lane. Separation of equal amounts of total protein (20 micrograms per 
lane) in a paired design (loading pattern) with SDS-PAGE that is samples from the time course 
of one subject (pre and post ULLS) were loaded on the same 7.5% SDS-PAGE gel. Each 
background-corrected band value was normalized to its corresponding Ponceau S stained actin 
band signal intensity on the respective gel; the values therefore reflect relative expression levels 
per total muscle protein in arbitrary units. Due to an insufficient amount of biopsy sample 
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available, we were unable to perform other tests, such as assessment of the phosphorylated S6K 
and FAK. 
 
 
4.2.5 Enzyme activities 
Homogenates were prepared from 20-micrometer cryosections in 0.1 M KH2PO4 buffer (pH 7.2) 
containing 2 mM EDTA on ice with the help of a Polytron mixer (Kinematica Switzerland). 
Protein concentration was quantified spectrophotometrically with the bicinchoninic acid protein 
assay kit (Perbio) and adjusted to 2 mg/ml. Samples were distributed in aliquots and stored at -
80°C. The quantification of chymotrypsin-like enzyme activity of the 20S proteasome was based 
on the hydrolysis of a fluorogenic substrate essentially as described (Berthon et al., 2007). In 
brief, 20 micrograms of muscle extract were incubated in a final volume of 1 ml imidazole buffer 
(60 mM, pH 7.4). The reaction was started by the addition of 100 μM of the fluorogenic 
substrate succinyl-leu-leu-val-tyr-7-amido-4-methylcoumarin (Bachem, I-1395). For cathepsin 
B/L activities, 10 micrograms of muscle extract were incubated in a final volume of l ml sodium 
acetate buffer (100 mM, pH 9.0) (Duguez et al., 2003). The assay was started by the addition of 
10 mM benzyloxycarbonyl-Phe-Arg-amido-4-methylcoumarin (Bachem, I-1160). Substrate 
conversion was assessed fluorometrically (excitation at 380nm and emission at 460nm) on a 
SFM25 fluorimeter (Kontron Instruments). Proteolytic activity was estimated based on a 
Michaelis-Menten type model of catalytic activity where the conversion rate (i.e. the increase in 
fluorometric signal per time) is proportional to Vmax. Measures were repeated in minute 
intervals over the first 10 minutes of the reaction and the mean conversion rate calculated. 
89 
 
Proteolytic activity (Vmax) was then calculated vs. standard curve of amido-4-methylcoumarin 
drawn from dilutions in the range of 0-150 pmol/ml. 
 
 
4.2.6 Immunocytochemistry 
15-micrometer cryosections of VL and SOL muscle were incubated with a 1:400 dilution of 
mouse monoclonal anti-fast myosin heavy chain antibody (MHCII) Clone MY-32 (Sigma-
aldrich) in 0.3% BSA in phosphate buffered saline (PBS), then reacted with a 1:2000 dilution of 
horseradish peroxidase-conjugated anti-mouse IgG (ICN). Immunoreactivity was detected with 
substrate solution, 3-amino-9-ethylcarbazole in dimethylformamide (Sigma Chemicals, Buchs, 
Switzerland). Sections were nuclei counterstained with hematoxylin and embedded in Aquatex 
(Merck, Germany). Sections were then used for fibre % and fibre cross-sectional area analysis. 
 
 
4.2.7 Fibre type percentage and cross-sectional area analysis  
Type I and type II myosin heavy chain stained sections were recorded digitally at 10X 
magnification on an Axioskop 2 microscope (Carl Zeiss Ltd, Welwyn Garden City, United 
Kingdom) that was operated with AxioVision software (Carl Zeiss Ltd, Welwyn Garden City, 
United Kingdom). Subsequently, one field from type II myosin heavy chain stained sections 
were assessed for cross-sectional area of stained (fast-type) and unstained (slow-type) fibers 
against a scale by manually recording the fibre periphery of each assessed fiber within the 
ARDOM software (Flueck et al., 2011). These numbers were used to calculate the percentage 
and mean cross-sectional area of slow and fast type muscle fibres. The area content of slow type 
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fibres was calculated using the formula: [area content of slow-type fibre = percentage of slow-
type fibres x mean cross-sectional area of slow-type fibers x 100].  
 
 
4.2.8 Statistical analysis 
Post vs. pre changes were assessed with repeated ANOVA and effects were localized with a post 
hoc test in function of the result of the Shapiro-Wilks test for normality (Statistica 9.1). In cases 
where the assumption of a normal distribution was rejected, a nonparametric one-tailed 
Wilcoxon test was employed to assess the post vs. pre effects. In any other cases, a student’s 
paired t-test was used to analyse data. A one-tailed t-test was employed in situations where single 
sided hypothesis could be formulated i.e. the increase in chymotrypsin-like and cathepsin B/L 
activities. For all data used n=9 pre and n=9 post. Significance was assigned at p<0.05.  
 
 
4.3 Results 
 
 
4.3.1 Muscle fibre type composition 
m.vastus lateralis had a typical fibre type distribution, with 26% more type II fibres than type I 
fibres (p=0.0003; two-tailed paired Student’s T-test). Type II fibres had a significantly elevated 
mean cross sectional area (MCSA) compared to type I fibres (p=0.008) (Table 4.1). 
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Figure 4.1 Microscopic images of muscle cross sections of m.vastus lateralis pre and post 21 
days of ULLS after staining for type II myosin type heavy chain (orange). Nuclei were 
counterstained with hematoxylin (blue). 
   
 
 
 
                                                    pre  post   
m. vastus lateralis 
 slow type: 4824±386 4158 ± 253  
 fast type: 5612 ± 404 4625 ± 254  
 
Pre Post 
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Table 4.1 Mean and standard error of the mean of the fibre cross sectional area of slow and fast 
type muscle fibres in m. vastus lateralis pre and post 3 weeks ULLS.  Significant difference was 
identified (two tailed Fisher-test). Type I fibres were reduced 14% in MCSA post ULLS 
compared to that of the pre samples from the same leg (p=0.030), whereas type II fibres showed 
a significant 21% lower MCSA. (p=0.006). 
 
 
4.3.2 Response to unloading 
There was a main effect of ULLS observed between parameters assessed combined as indices of 
negative (i.e. chymotrypsin-like enzyme of 20S proteasome and cathepsin B/L enzyme activities) 
and positive (i.e. type I fibre MCSA, type II fibre MCSA, protein content of FAK and p70S6K) 
protein balance (p=0.0001; repeated ANOVA Statistica 10.0 ). 
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Figure 4.2 Representative immunoblots visualizing the detected proteins, FAK and p70S6K 
from total homogenate of m.vastus lateralis pre- and post-ULLS for the same subject. Ponceau S 
stained actin bands are shown as a loading control. 
 
 
4.3.3 Fibre atrophy with unloading 
Both type I and type II fibres showed a significantly lower MCSA after 21 days of ULLS. Type I 
fibres were reduced 14% in MCSA post ULLS compared to that of the pre samples from the 
same leg (p=0.030), whereas type II fibres showed a significant 21% lower MCSA (p=0.006) 
(Fig. 4.3). The reported muscle fibre atrophy is fibre type independent (p=0.297, two-tailed 
paired Student’s T-test). Type II fibre continued to show significance for a larger MCSA than 
that of type I fibres post ULLS (p=0.043). 
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Figure 4.3  Bar graph showing mean and standard error of the mean of the fibre cross-sectional 
area of slow and fast type muscle fibres in m. vastus lateralis pre and post 3 weeks of ULLS.  * 
p<0.05 identified (two-tailed Fisher-test). 
 
 
4.3.4 Effects of unloading on protein expression 
Figure 4.2 shows representative immunoblots of the measured anabolic signaling proteins. After 
21 days of ULLS, there was a trend for a reduction of FAK protein content (p=0.07, two-tailed 
paired Student’s T-test). Moreover, FAK protein content developed a positive correspondence 
with type I fibre percentage as well as the percentage area content of type I fibres post ULLS 
(r=0.64 and r=0.62 respectively). The total protein level of p70S6K was unchanged with 
unloading (p=0.20) (Fig. 4.4). 
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Figure 4.4 Bar graph showing mean and standard error of FAK and p70S6K protein level 
changes with 21 days of ULLS in m.vastus lateralis. + p<0.10 (two-tailed paired Student’s T-
test). 
 
 
4.3.5 Proteasomal activity 
In order to determine whether there were changes in indices of proteolytic activity in m.vastus 
lateralis after 27 days of ULLS, we assessed the activity of chymotrypsin-like enzyme of 20S 
proteasome of the ubiquitin-proteasome pathway known as the main contributor to target 
sarcomeric proteins, and also that of cathepsin B/L, the primary enzymes of the lysosomal 
pathway to function in skeletal muscle degradation. Cathepsin B/L and chymotrypsin-like 
enzymes showed a trend for elevated activities post ULLS (p=0.057 and p=0.057 respectively; 
one-tailed Wilcoxon) (Fig 4.5). The percentage change in activity of Cathepsin B/L following 
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unloading was positively correlated with that of chymotrypsin-like enzyme and there was a 
strong positive correlation between the activity levels of both enzymes post ULLS (r=0.92 and 
r=0.95 respectively).  
 
 
 
 
 
Figure 4.5 Effect of 21 days ULLS on chymotrypsin-like enzyme activity of 20S proteasome 
and cathepsin B/L enzyme activities. Enzyme activities are expressed as pmol min-1 mg-1 protein 
(n=9). Values are means ± SE. Pre control group; Post unilateral limb suspension for 21 days, * 
p<0.10 (one-tailed Wilcoxon). 
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4.4 Discussion 
 
 
4.4.1 A decrease in the mean cross-sectional area of both fibre types are detected in 
m.vastus lateralis following 21 days of ULLS. 
Animal studies of disuse have shown that the mechanisms responsible for the muscle atrophy 
involve a decrease of protein synthesis accompanied by an increase of protein degradation 
(Fujino et al., 2009). Few investigations to date have been carried out in humans (Murton et al., 
2008). As a result, the actual regulatory mechanisms governing human conditions of disuse 
atrophy are unresolved. Our investigation suggests that after 21 days of muscle deconditioning, 
the observed muscle fibre atrophy is associated with elevated proteolytic activity and reduced 
anabolic signaling.  
In general, this study is limited by a small sample size and an inter-subject variability. There was 
a significant main effect indicative of unloading induced differential response between factors 
representing negative and positive protein balance. The structural alterations in muscle submitted 
to unloading are illustrated first by muscle atrophy. After 21 days ULLS, we observed a 14% 
decrease in MCSA of type I fibres and a 21% reduction in that of type II fibres in m.vastus 
lateralis, which is consistent with the general concept that anti-gravity extensor muscles of the 
lower limb experience the greatest atrophy in response to inactivity and unloading (Belavy et al., 
2009). But the magnitude of reduction of our data seems to be greater than those findings from 
previous work, with observed CSA measures in the order of an 8-9% decline after 16-28 days of 
ULLS (Narici and de Boer 2011). However, non-significant reductions in MCSA of type I and 
type II muscle fibres of m.vastus lateralis have been reported to amount to 11 and 24 % after 5 
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days of spaceflight. The reduction in MCSA of both fibre types was fibre-type independent 
(p=0.297). This fibre independence is supported by an earlier experiment showing the rates of 
atrophy being unrelated to the proportion for type I muscle fibres (Blottner et al., 2006). 
Similarly, another study has reported a preferential atrophy of the slow-oxidative type I fibres in 
rats, but not in humans. The author has suggested that atrophy of type II fibres is comparable, if 
not greater than, that of slow type I fibres (Fitts et al., 2000). 
 
 
4.4.2 A reduced protein level of FAK happens to positively correlate with the percentage 
number and area content of type I fibres. 
Although it is widely recognized that mechanically induced tension plays a critical role in the 
regulation of the skeletal muscle mass (Hornberger and Chien 2006, Hornberger et al., 2006), the 
events linking mechanical stimuli to the anabolic signaling pathways remain still not thoroughly 
understood. To date, focal adhesion kinase (FAK) has been considered as a signaling molecule 
associated with mechano-transduction (Durieux et al., 2007, Klossner et al., 2009). Its tyrosine 
phosphorylation at residue 397 reflects the mechano-chemical coupling between mechanical 
stimulation of integrins and activation of intracellular signal transduction. The total amount and 
phosphorylation state of FAK are reportedly increased during load-induced muscle hypertrophy 
in conjunction with elevated myofibrillar content in vivo and in vitro. Based on our experiment, 
there was a trend for a decrease of FAK total protein, which corresponds to the observations of 
reduced levels of phosphorylated FAK and its protein content after 10 days ULLS intervention in 
humans in association with a 50% decrease in the fractional rate of myofibrillar protein synthesis 
(de Boer et al., 2007b). Our finding reinforces the notion of FAK as an upstream modulator of a 
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mechano-regulated pathway to protein synthesis (Klossner et al., 2009), and suggests that this 
protein is responsible for eliciting the decline in muscle protein synthesis through decreased 
anabolic signaling at 21 days of human skeletal muscle disuse atrophy. 
In addition, the content of FAK was positively correlated with the percentage of type I fibres and 
the percentage area content of type I fibres at 21 days ULLS (r=0.64 and r=0.62 respectively). 
These correlations are the first human data to support the findings from animal studies. Whereby, 
sarcolemmal FAK concentration was found to correspond to the degree of muscle fibre 
recruitment for contraction with an elevated FAK content being found in slow-oxidative muscle 
fibres that experience a high degree of load-bearing activity. More recently, a muscle-targeted 
transgenic investigation in rat has identified FAK as a load-dependent governor of the slow-
oxidative muscle phenotype (Klossner et al., 2009). 
 
 
4.4.3 Protein content level of p70S6 kinase remains unchanged  
The level of p70S6 kinase did not alter with unloading. Although we haven’t measured the 
phosphorylated state of this protein, it was shown by another 21 days ULLS study that there was 
no alteration in either activity or content of p70S6K (de Boer et al., 2007b). (I have spent about 
two months last year to try to detect the phosphorylated state of s6k without the 
immunoprecipitation step but failed, and the rest remaining samples is not sufficient to carry out 
immunoprecipitation). However, this does not exclude its involvement as an upstream regulator 
of translation initiation with the decreased protein synthesis rate in disuse atrophy, but could 
rather suggest that the time point when the biopsies were taken did not coincide with the 
transient change of the protein. A decreased p70S6K phosphorylation has coincided with a 
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reduced translation rate in animal models of muscle disuse (Bodine et al., 2001b, Hornberger et 
al., 2001). In fact, Flueck and colleagues have demonstrated an existing temporal relationship 
between FAK and its downstream effector p70S6K, by which enhanced FAK signaling resulted 
in a delayed response of p70S6K (Klossner et al., 2009). Furthermore, an increase in the 
phosphorylation status of p70S6K was not observed after a resistance training programme. Its 
author has regarded the result as a response of negative feedback of p70S6K being auto-
regulated by eIF-4E to reach cellular translational homoeostasis and to prevent uncontrolled 
growth, rather than an indication its inactivation during human skeletal muscle hypertrophy 
(Gautsch et al., 1998). 
 
 
4.4.4 Chymotrypsin-like activity of the 20S proteasome and cathepsin B/L enzyme activities 
are elevated after 21 days of ULLS in humans. 
This study is the first to show a trend of increase in chymotrypsin-like activity of the 20S 
proteasome in a human disuse model, which is in line with the data from animal disuse programs, 
where a classical activation of the ubiqutin–proteasome pathway has been indicated by reported 
increases in mRNA expression, protein level and activity of various UPS constituents (Berthon et 
al., 2007, Murton et al., 2008, Fujino et al., 2009). While in humans, elements of the UPS, 
notably levels of ubquitinated proteins and HC6 mRNA appear elevated in a bed rest and an 
immobilization studies respectively, the vast majority of human disuse experiments performed to 
date have been focused on mRNA expressions of two E3 ligases, MuRF1 and MAFbx. The 
resulting variable findings in regard to MAFbx and MuRF-1 levels and a general absence of their 
protein content measures render the role of UPS in muscle atrophy to be questioned (Murton et 
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al., 2008). Our observation based on assessing chymotrypsin-like activity of the 20S proteasome 
is indicative of a role for ubquitin-proteasome proteolysis in human chronic unloading. We also 
happen to be the first to have found a trend for an elevation of the cathepsin B/L enzyme 
activities in humans. A survey of the literature shows no studies to date have investigated the 
lysosomal degradation pathway under human disuse conditions. Our findings are supported by 
the available data from animal unloading programs showing marked increase in various isoforms 
of cathepsin mRNAs and increase in cathepsin protein or activity levels (Sakamoto and 
Goodyear 2002). 
 
 
4.4.5 Evidences for close regulation of the ubiquitin-proteasome system and the lysosomal 
degradation pathway during disuse atrophy are observed. 
Strong positive correlations were established between the activity levels of cathepsin B/L and 
chymotrypsin-like enzymes post ULLS as well as their percentage increase in activity. This 
observation reinforces the notion from in vitro and in vivo studies that the two main mechanisms 
responsible for the majority of cellular protein degradation, lysosomal proteolysis and UPS are 
being closely regulated and an interaction of both mechanisms has been proposed to govern 
muscle protein breakdown during muscle atrophy. Evidence has shown that lysosomal 
proteolytic pathway seems to operate in conjunction with the ubiquitin-proteawsome pathway for 
degradation of specific protein substrates (Bechet et al., 2005, Zhao et al., 2007). A coordinated 
stimulation of both degradation pathways accompanying a decrease of the net proteolytic rate 
have been observed in animal models of disuse. More importantly, two in vivo studies now 
implicate that FOXO3 transcription factor can cause marked atrophy through coordinately 
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regulating the transcription of components of lysosomal and ubquitin-poteasomal systems 
(Mammucari et al., 2007, Zhao et al., 2007). 
 
 
4.5 Conclusion 
After 21 days of unilateral unloading (ULLS), muscle fibre atrophy has been in association with 
decreased FAK protein levels and strongly correlated increases of lysosomal and ubiquitin-
proteasomal proteolytic activity. The latter observation is indicative of the two proteolytic 
systems being coordinately regulated and possibly reflects their close interaction during protein 
degradation. In summary, the human disuse atrophy data favors the proposition, based on animal 
studies, that the regulatory mechanisms governing disuse atrophy involve decrease of protein 
synthesis and increase of protein degradation. 
 
 
 
 
 
 
 
 
 
 
5. Costamere remodeling with muscle loading and unloading in healthy young men 
 
 
5.1 Introduction 
 
103 
 
Skeletal muscle size shows a pronounced mechano-dependence, notably increasing in size with 
chronic overloading and decreasing in size with chronic unloading, as for example during 
experimental bedrest (Loughna et al., 1986). Changes in mean muscle cross-sectional area (CSA) 
and fascicle pennation angle can be observed within a few days of altered loading in humans 
(Narici and Maganaris 2007, Hackney and Ploutz-Snyder 2012). For instance, atrophy is 
detectable as early as after 7 days of bedrest (Ferrando et al., 1995) in anti-gravity muscle m. 
vastus lateralis, and aggravates progressively with prolonged unloading until 6 months 
(Bloomfield 1997, Hackney and Ploutz-Snyder 2012). Similarly, hypertrophy of m. vastus 
lateralis can be detected after as few as 10 sessions of eccentric-type resistance exercise in 3 
weeks, further increasing with the progression of the training period (Seynnes et al., 2007).  
Changes in muscle size are largely driven by modified content of myofibrils, which involves 
adaptations of both slow- and fast-type fibers (Fry 2004, Borina et al., 2010). With unloading, 
atrophy is observed for both slow type I, and fast type IIA and IIX muscle fibers (Bloomfield 
1997, Fitts et al., 2001, Hackney and Ploutz-Snyder 2012). Based on changes in myosin heavy 
chain (MHC) expression with prolonged unloading, there may also be a conversion of slow- into 
fast-type muscle fibers, leading to a relative increase in fast- over slow-type MHC content 
(Bloomfield 1997, Hackney and Ploutz-Snyder 2012). An increase in nitrogen excretion suggests 
that altered myofibrillar makeup contributes to the observed muscle atrophy after 7 days of 
unloading in humans (Bloomfield 1997). More recently, the use of stable isotopes has enabled to 
show a 50% reduction in myofibrillar protein synthesis within 10 days of lower limb unloading 
in humans (de Boer et al., 2007a,b). Conversely, an increase in myofibrillar synthesis rate 
implicates the contribution of increased MHC synthesis to the elevated CSA of both slow- and 
fast-type muscle fibers after resistance-type exercise (Williamson et al., 2001, Fry, 2004, 
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Wilkinson et al., 2008). Despite its apparent importance (Adams et al., 2003, Chopard et al., 
2009), the question arises of how such myofibrillar alterations are integrated between the 
molecular and the architectural level in muscle fibers that undergo adaptive changes. 
Sites of focal adhesion in the sarcolemma (costameres) are critical for the attachment of 
myofibrils to the fiber periphery (Ervasti 2003, Grounds et al., 2005). They assemble through the 
binding of cytoskeletal and signaling molecules to the intracellular inside of integrin-type and/or 
dystrophin/sarcoglycan-type extracellular matrix receptors (Miyamoto et al., 1995, Ervasti 2003, 
Grounds et al., 2005, Trimarchi et al., 2006). Thereby, costameres provide an anchor for the 
intermediate filaments that hold sarcomeres in register and establish a physical link between 
neighboring muscle fibers via the interstitium (Pardo et al., 1983, Ervasti 2003, Grounds et al., 
2005, Ramaswamy et al., 2011). Assembly of new costameres is essential for myofibrillogenesis 
in culture by providing a platform for the attachment of myofibril/myosins (Quach and Rando 
2006). The association between costameres and myofibrils is of great interest given that 
mechanical factors exert important control over the expression of costamere components and 
fiber size in anti-gravity muscle (Flueck et al., 1999, Gordon et al., 2001, Chopard et al., 2002, 
Chopard et al., 2005, Anastasi et al., 2008). For example, expression of the costamere 
components gamma- and meta-vinculin, talin, and b1-integrin is compromised with prolonged 
muscle unloading and muscle inactivity when muscle sarcomeres are lost (Chopard et al., 2002, 
Chopard et al., 2005, Anastasi et al., 2008). By contrast, concomitant resistance-type exercise 
prevents alterations in costamere components in unloaded muscle (Chopard et al., 2005). 
Interestingly, costamere component expression also varies between fiber types (Shear and Bloch 
1985, Bozyczko et al., 1989, Schröder et al., 1997, Williams et al., 2000, Flueck et al., 2002, 
Thoss et al., 2013). Owing to their role in myofibril attachment, the mechano-regulation of 
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costamere components is suggested to reflect active phases of muscle remodeling and fiber-type 
transformation with altered loading. 
The integrin-associated focal adhesion kinase (FAK) is instrumental for costamerogenesis in 
culture (Quach and Rando 2006). Overexpression of FRNK, which competes with FAK for 
binding to focal adhesions, implies that this involves the control over focal adhesion turnover via  
the interaction between focal adhesion components (Ilic et al., 1995, Schlaepfer et al., 2004). 
Phosphorylation of FAK at tyrosine residue 397 is an important control point of this regulation. 
It alters the capacity of FAK to interact with binding partners such as the tyrosine kinase c-src, 
enabling FAK to develop its full catalytic activity, phosphorylate auxiliary sites and enter 
interactions with further binding partners (Schlaepfer et al., 1999) that mediate the clustering of 
cytoskeletal and signaling proteins to integrins (Miyamoto et al., 1995). A number of 
observations highlight that both phosphorylation of Y397 and auxiliary sites, as well as the 
content of FAK, is load-regulated (Li et al., 1997, Aikawa et al., 2002, Torsoni et al., 2003, Lal 
et al., 2007). For instance, FAK-pY397 content is increased in relation to enhanced FAK protein 
content after the first day of chronic overload in rat soleus muscle (Flueck et al., 1999, Gordon et 
al., 2001, Durieux et al., 2009). Conversely, muscle unloading downregulates FAK tyrosine 
phosphorylation within 7 days in rat and human skeletal muscle, and this is confounded by an 
upregulation of FAK protein content in rat muscle (Gordon et al., 2001, de Boer et al., 2007b). 
Likewise, components of the dystrophyin/sarcoglycan-type receptor demonstrate mechano-
regulated expression and are involved in mechanical signal transduction in skeletal muscle 
(Barton 2006, Chopard et al., 2005). Increased FAK amount in rodent skeletal muscle appears 
also to promote the load-regulated activation of the serine/threonine kinase p70S6K (the positive 
regulator of protein synthesis), which is robustly associated with increased protein synthesis and 
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hypertrophy with muscle overload (Baar and Esser 1999, Terzis et al., 2008, Wilkinson et al., 
2008, Klossner et al., 2009, Carter and Flueck 2012).  
We reasoned that loading-dependent plasticity of muscle size is integrated through costamere 
turnover via a load-regulated process that involves level alterations of FAK and FAK-pY397 
concentration. The functional implication of FAK in the hypothesized mechano-regulation of 
costamere remodeling was studied by quantifying the concentration of the focal adhesion 
components, meta- and gamma-vinculin, beta 1 integrin, and p70S6K in relation to concentration 
changes in FAK, FAK-pY397 and its inhibitor FRNK during increased loading and unloading of 
human vastus lateralis muscle. We thus hypothesized that the changes in costamere components 
through the course of increased muscle loading with eccentric-type resistance training and 
unloading by bedrest would be inter-related with FAK-pY397. As costameres are connected to 
the cytoskeletal elements that hold sarcomeres in register, we expected that costamere protein 
levels exist in a constant proportion to muscle size (muscle thickness or CSA), except during 
phases of muscle remodeling characterized by the formation or removal of myofibrils (i.e. fiber 
transformation and atrophy). This was tested by comparing the changes in muscle size with those 
of costamere protein levels during the course of altered loading of m. vastus lateralis in humans. 
Time points for the sampling of bioptic material were selected on the basis of documented 
anatomical changes with the two loading interventions (Ferrando et al., 1995, de Boer et al., 
2007a, Seynnes et al., 2007). 
 
 
5.1.1 Aim and hypothesis 
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The aim of the study was to investigate the role of costameres in the regulation of muscle size 
with altered muscle loading. For this purpose we assessed the association of level changes in 
costameres components and its upstream regulator, FAK, with changes in muscle thickness and 
CSA following bedrest and resistance training. We hypothesized that changes in content of 
costamere components (beta 1 integrin, FAK, meta-vinculin, gamma-vinculin) with increased 
and reduced loading of human anti-gravity muscle would i) relate to changes in muscle size and 
molecular parameters of muscle size regulation (p70S6K, MHC1 and MHCIIA), ii) correspond 
to adjustments in activity and expression of FAK, and its negative regulator, FRNK, and iii) 
reflect the temporal response to reduced and increased loading. 
 
 
5.2 Methods 
 
 
5.2.1 Experimental design 
Anti-gravitational muscle (m. vastus lateralis) of untrained human subjects was subjected either 
to unloading by bedrest (experimental Group 1) or to overloading by resistance training 
(experimental Group 2). In both groups, anatomical measures were taken to estimate muscle size 
and muscle fiber CSA, and a muscle sample was collected to determine the content of costameric 
proteins (FAK, FRNK, beta 1 integrin, meta-vinculin, gamma-vinculin) and the phosphorylation 
status of FAK at pY397, and where appropriate the content of p70S6K. All subjects gave their 
written informed consent to participation in the study, which had been approved by the Ethical 
Committee of the University of Primorska for subjects of Group 1 and by the local Ethics 
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Committee of Manchester Metropolitan University for subjects of Group 2. Muscle tissue was 
collected and stored under the United Kingdom’s Human Tissue Act. 
 
 
5.2.2 Bedrest (Group 1) 
These experiments were carried out in the Orthopedska Bolnica Hospital in Valdoltra, Ankaran 
(Slovenia) under medical supervision. Nine healthy Caucasian young men (age: 24.3± 2.6 years; 
stature: 179.7±8.0 cm; body mass: 76.4±10.4 kg) from the Slovenia area were recruited for this 
study via advertisement in a student job portal and via word of mouth. Muscle thickness was 
determined after the 8th and 34th day of bedrest (see ‘Muscle anatomy’ below). On this occasion, 
a muscle biopsy sample was collected with a conchotome under local anaesthesia from the belly 
portion of the vastus lateralis muscle (~80-150 mg). Samples were snap-frozen in liquid nitrogen 
and stored until use at -80°C.  
 
 
5.2.3 Resistance training (Group 2) 
Six healthy Caucasian men (age: 22.3 ± 1.5 years; stature: 175.2 ± 3.4 cm; body mass 71.0 ± 4.6 
kg) from the student population of Manchester Metropolitan University participated in this study. 
Unilateral leg extension was performed three times per week for 9 weeks on a flywheel 
ergometer (YoYo Technology, Sweden; Seynnes et al., 2007). In brief, resistance is produced 
from the inertia of the flywheel during both concentric and eccentric contraction phases, by 
virtue of the unwinding/rewinding of a strap connecting the flywheel to the lever arm. Each 
session consisted of one set of seven submaximal leg extensions as a warm-up, and was 
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proceeded by four sets of 10 maximal coupled concentric and eccentric contractions, with 2-min 
rest periods between sets. Subjects were tested for vastus lateralis muscle thickness and 
quadriceps femoris CSA on three occasions (see ‘muscle anatomy’ below): at baseline, 4 weeks 
before the first training session (pre-training); after the 10th training session (mid-training) and 
after the 27th training session (post-training). Bioptic samples were collected pre-training, mid- 
and post-training from lignocaine-anaesthetized vastus lateralis muscle. For the training samples 
the interval between the preceding exercise bout and muscle sampling was 4-6 h.  
 
 
5.2.4 Muscle anatomy  
Group 1 
Muscle thickness was measured by using B-mode ultrasound scanning (Mylab 25, 13-4 MHz, 
linear array transducer probe LA523; Esaote Biomedica, Geneva, Italy). Scans were performed 
at mid-muscle length along the mid-sagittal axis of the vastus lateralis, perpendicular to the 
lower aponeurosis plane. Thickness was defined as the average of three equidistant 
measurements along the scan width, between the superficial and deep aponeuroses of the muscle. 
The consistency of ultrasound scanning between the testing sessions was ensured by recording 
the location and orientation of the transducer on transparent acetate paper. 
 
Group 2 
The methods for assessing maximum anatomical CSA of the vastus lateralis muscle have been 
described in detail elsewhere (Erskine et al., 2009). Briefly, the upper leg was scanned using a 
0.2-T magnetic resonance imaging scanner (G-Scan, EsaoteBiomedica, Genoa, Italy), adhering 
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to a Turbo 3D T1-weighted sequence with the following scanning parameters: time of repetition 
40 ms; time to echo 16 ms; matrix 256 x 256; field of view 180 mm x 180 mm; slice thickness 
2.8 mm; interslice gap 0 mm. Contiguous axial slices were taken from the tibiofemoral joint to 
the iliac crest perpendicular to the femur, with the participant in the supine position. From the 
contiguous slices, the maximal anatomical CSA of the vastus lateralis muscle was identified and 
manually outlined (Osirix 2.7.5, Osirix Foundation, Geneva, Switzerland). Muscle thickness was 
quantified by ultrasound with the same approach used for Group 1. 
 
 
5.2.5 Cross-sectional area of muscle fibers 
Twelve-micrometer cryosections were prepared from muscle biopsies and subjected to fiber 
typing using mouse anti-type II MHC and Alexa Fluor 555-coupled secondary anti-mouse 
antibody (DAKO) essentially as described (Flueck et al., 1999, Gordon et al., 2001, Durieux et 
al., 2009, Klossner et al., 2009). The fluorescent signal was digitally recorded from different 
microscopic fields with standardized settings using a TCS SP5 confocal microscope (10 x 
objective and 4 x zoom; Leica Microsystem CMS, Milton Keynes, UK). Image files were 
exported and the CSA of stained (type II) and non-stained (type I) fibers in a given microscopic 
field was quantified using image J 1.6.0_33 J (http://imagej.nih.gov/ij). Numerical values for the 
same fiber type from the different microscopic fields of a muscle cross-section were pooled to 
calculate for each muscle biopsy the mean CSA of type II and type I fibers, and the percentage in 
muscle area covered by type I fibers (Flueck et al., 2011). On average, 45 and 84 type I and type 
II muscle fibers, respectively, were counted per muscle biopsy (subject). The mean coefficient of 
variance for the estimation of CSA per subject was 4%. 
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5.2.6 Immunodetection of FAK in sections 
Staining of muscle sections for FAK was carried out with fluorescence essentially as described in 
Klossner et al. (2009). Twelve-micrometer cryosections were freshly prepared from pre- and 
post-unloading sample of subjects and assembled onto the same slides. Sections were left to dry 
and fixed with 4% paraformaldehyde/0.1% Triton X-100 for 30 min, quenched with 3% H2O2 
and blocked in 3% bovine serum albumin (BSA) in phosphate-buffered saline (PBS). 
Subsequently, sections were incubated with a 1:100 dilution of FAK C-terminal antibody 
(Flueck et al., 1999, Gordon et al., 2001, Chopard et al., 2002, Chopard et al., 2005, Anastasi et 
al., 2008) and mouse anti-type I MHC (Durieux et al., 2009) in 3% BSA-PBS overnight at 4°C, 
followed by washes in PBS and incubation with a 1:400 dilution of Alexa Fluor 488-coupled 
secondary anti-rabbit antibody (DAKO) and Alexa Fluor 555-coupled secondary anti-mouse 
antibody (DAKO). Nuclei were stained using 5-min incubations with TO-PRO3 (Invitrogen). 
Fluorescence and digital phase contrasts were recorded at standardized settings (10 x objective 
and 4 x zoom) using a TCS SP5 confocal microscope (Leica Microsystem CMS, Milton Keynes, 
UK).  
Subsequently, image files were taken from different microscopic fields of a stained muscle 
section and exported as tiff files. The signal intensity of FAK at the sarcolemma was inspected 
and quantified using image J 1.6.0_33 J (http://imagej.nih.gov/ij). Fibers were categorized for 
fiber type and sarcolemmal FAK content (positive or negative). Fibers were classified as positive 
when staining was identified along at least two edges of the generally squared human muscle 
fibers, as described elsewhere (Flueck et al., 2002, Evans et al., 2008). The number of fibers in 
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each of the four categories (i.e. type I-FAK+, type I-FAK-; type II-FAK+, type II-FAK-) was 
determined for each muscle from counting of different, non-overlapping microscopic fields. 
Statistical significance of changes in the frequency of FAK staining with unloading was assessed 
essentially as previously described (Flueck et al., 2003). First, the frequency of FAK staining at 
the sarcolemma of all combined muscle fibers of a given biopsy was assessed for a difference 
pre- vs. post-unloading with a Chi2-test (p<0.05). If statistical significance was reached, the 
percentage of FAK staining at the sarcolemma was calculated for type I and type II muscle fibers, 
respectively, and each muscle section, and compared for significance of a differences post- vs. 
pre-unloading with a two-tailed paired t-test. On average 23 and 59 type I and type II muscle 
fibers, respectively, were counted per muscle biopsy and subject. 
 
 
5.2.7 Protein detection 
Muscle was cryosectioned at 12 μm, and total homogenate was prepared in modified RIPA 
buffer (1% NP-40, 0.25% deoxycholate, 50 mM Tris-HCl, pH 7.4, 1 mM EDTA, 150 mM NaCl, 
1 mM NaF, 1 mM PMSF, 1 mM sodium orthovanadate, 1 µg/ml leupeptin, 2 µg/ml pepstatin, 
and 1 µg/ml aprotinin; all reagents were received from Sigma). Protein concentration was 
quantified with bicinchoninic acid assay reagents against BSA standard (Pierce). Twenty 
micrograms of protein was separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel 
electrophoresis, Western blotted onto nitrocellulose (Schleicher & Schuell). Gel loading was in a 
paired design with pre-, mid- and post-intervention samples of three subjects being applied in 
adjacent lanes per gel. The membrane was stained with Ponceau S to verify equal loading from 
the intensity of detected protein bands, including the major signal at 40 kDa that corresponds to 
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skeletal alpha actin. Subsequently membranes were subjected to immunodetection with specific 
antibodies against slow-type MHC, fast-type MHC, FAK, FRNK, beta-1 integrin, gamma-
vinculin, meta-vinculin, p70S6K, essentially as described (Flueck et al., 1999, Gordon et al., 
2001, Durieux et al., 2009, Klossner et al., 2009). For the detection of fast-type myosin, the 
immunblot was stripped after signal development for slow-type myosin by incubating for 30 min 
at 65°C in (62.5 mM Tris, pH 6.8, 1% SDS, 0.7% beta-mercaptoethanol) with occasional 
shaking followed by extensive rinses in 0.5% Tween-20 in Tris-buffered saline. Content of FAK-
pY397 was assessed in FAK-immunoprecipitates from the supernatant of 1 mg total protein as 
described (Klossner et al., 2009). Signal detection was carried out with enhanced 
chemoluminescence using a Geldoc system that was operated using Quantity One 1-D analysis 
software 4.6.1 (Bio-Rad Laboratories, Hemel Hempstead, UK). Signal intensity of the protein 
bands was determined using the rectangle density mode and background from an empty sample 
lane of equal size was subtracted. Background-corrected data were normalized to the mean 
values of the pre-samples for the respective gel; the values therefore reflect relative expression 
levels per total muscle protein. 
 
 
5.2.8 Statistics 
Alterations in ‘muscle parameters’ (muscle thickness, CSA, FAK, FRNK, FAK-pY397, meta-
vinculin, gamma-vinculin, p70S6K, MHCI, MHCIIA) through the ‘time course’ (pre-, mid-, 
post-) of the particular ’loading condition’ (i.e. unloading and overloading) were assessed with a 
repeated ANOVA for the repeated factor ‘time course’ using Statistica 9 (StatsoftInc, Tulsa, 
USA). A Wilcoxon test was used to localize the effect between time points of muscle 
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unloading/overloading. Effects were called significant at p < 0.05. Pearson correlations were 
calculated to identify linear relationships that were deemed biologically significant if r > 0.65 
and p < 0.10. 
 
 
5.3 Results 
 
 
5.3.1 Changes in muscle thickness and cross-sectional area 
Table 5.1A and B, respectively, show the changes in muscle thickness with unloading by bedrest 
(Group 1) and overloading with eccentric-type of resistance training (Group 2). Muscle 
unloading produced a progressive reduction in thickness of vastus lateralis muscle (Table 5.1A). 
This was reflected by atrophy of type I muscle fibers (Table 5.2A). A tendency (p=0.08 and 0.06 
for changes mid- and post-bedrest, respectively) for a reduction in mean CSA of type II fibers 
was also observed (Table 5.2A).  
Muscle overload increased the thickness and maximal anatomical CSA of vastus lateralis muscle 
(Table 5.1B). Neither the daily nor sessional percentage change in muscle thickness differed 
between the first and second intervention phase, either for bedrest (p=0.58) or resistance training 
(p=0.72). Mean CSA of type I (+34%), but not type II, muscle fibers was increased with 
resistance training, and this differed between the first and second phase of training (Table 5.2B). 
The percentage of type I fibers was 40 and 41%, respectively, before bedrest and resistance 
training, and this was not affected by the intervention (P>0.19). Changes in CSA of type I and 
type II muscle fibers over all interventions were correlated with those of muscle thickness (Fig. 
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5.5A). Mid-way into the combined response to unloading or overloading, only the changes in 
CSA of type I fibers were correlated with those of muscle thickness (Fig. 5.5B). 
 
 
 
A)  
 Pre Mid Post 
Muscle thickness (mm) 
(bed rest) 
22.1 ±1.8 21.6 ±1.9* 19.0±1.6* 
Muscle thickness (mm) 
(resistance training ) 
23.1±1.6 24.7±1.5 24.9 ±1.6* 
 
B) 
 Mid vs. pre Post vs. mid 
Delta (%) of muscle thickness 
(bed rest) 
-2.7 ±0.9 -16.8 ±2.4† 
Delta (% per session) -0.34±0.11 -0.49±0.07 
Delta(%) of muscle thickness 
(resistance training) 
3.7±2.2 13.6±2.7 
Delta (% per session) 0.37±0.22 0.51±0.10 
 
 
 
Table 5.1 Opposite changes in muscle size with reduced and increased muscle loading. A) 
Median and standard error (SE) of muscle thickness (in mm). B) Percentage changes in muscle 
thickness of vastus lateralis after 8 days (mid) and 34 days (post) of unloading by bed rest and 
percentage changes in muscle thickness of vastus lateralis after 10 sessions (mid) and 27 sessions 
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(post) of overloading by resistance type training (n=6). * denote p˂0.05 vs. pre intervention 
levels (Wilcoxon-test). †, significant effect of' 'time'(repeated ANOVA). 
 
 
 
 
 
 
 
A)  
 Pre Mid Post 
Type I mean CSA (µm²) 
(bed rest) 
6113±734 4515±633* 4244±884* 
Type II mean CSA(µm²) 
(bed rest ) 
7245±1256 5898±1049+ 5663±1397+ 
Type I mean CSA (µm²) 
(resistance training) 
4530±1151 4690±1200+ 6058±1095* 
Type II mean CSA(µm²) 
(resistance training) 
6135±1337 6353±798 6863±744 
 
B) 
 Mid  vs. pre Post vs. mid 
Delta (%) of Type I mean CSA  
(bed rest) 
-27.1± 2.0 -29.5± 8.7 
Delta (%) of Type II mean CSA 
(bed rest) 
-10.0±7.9 -14.8±7.5 
Delta (%) of Type I mean CSA 
(resistance training) 
8.5±2.5 16.1±13.1† 
Delta (%) of Type II mean CSA 
(resistance training) 
3.6±8.7 11.9±11.1† 
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Table 5.2 Fibre cross sectional area with altered muscle loading. A) Median and standard error 
(SE) of mean CSA of type I and type II muscle fibres in vastus lateralis. B) Percentage changes 
in mean CSA of type I and type II fibres in vastus lateralis after 8 days (mid) and 34 days (post) 
of bed rest (n=4) and 10 sessions (mid) and 27 sessions (post) into resistance type training (n=5). 
*and + denote p˂0.05 and 0.05≤p˂0.10 vs. pre intervention levels (Wilcoxon- test). †, significant 
effect of 'time'(repeated ANOVA). 
 
 
5.3.2 Molecular factors of muscle size regulation during bed rest and resistance training  
Molecular parameters of muscle size regulation (p70S6K, MHCI, MHCIIA) demonstrated an 
interaction effect between the ‘time point’ x ‘loading condition’ (p=0.04). Bed rest did not 
modify the content of MHCI or MHCII, or p70S6K (Fig. 5.1A,B,E). The content of the slow 
MHC, MHC I, increased at the mid-point of resistance training, and p70S6K protein was reduced 
in the end- vs. the mid-point of training (Fig. 5.1C,D,F). 
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Figure 5.1 Level alteration of factors related to muscle size with modified muscle loading. 
A-D) Representative detection of p70S6K (A,C) and MHCI and MHCII (B,D) in western blots 
        
Mid          
Post 
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of 20 microgram total protein in muscle homogenate during the course of unloading (A,B) or 
overload (C,D). E, F) Median and SE of changes in p70S6K, MHCI and MHCII protein levels 
per total protein during the time course of bedrest (B; n=9) and resistance training (D; n=6). * 
and + denote p < 0.05 and 0.05 ≤ p<0.10 for the indicated comparison (Wilcoxon-test).  
 
 
5.3.3 Costameric protein expression with altered muscle loading 
There was an interaction effect between the ‘time point’ x ‘loading condition’ for the two 
parameters associated with costameres, FAK-pY397 and meta-vinculin. Levels of both 
parameters were not altered in response to bedrest (Fig. 5.2). With muscle overload a biphasic 
response of both, FAK-pY397 and meta-vinculin, and gamma-vinculin content was evident; all 
increasing between the mid- and end-point of resistance training (Fig. 5.3B,C,E,F). Changes in 
meta-vinculin and FAK-pY397 content were correlated over all sampled data points (r=0.80), 
and this was pronounced when only changes at the end of the intervention were compared 
(r=0.85). Muscle overload also increased beta 1 integrin mid- but not at the end of resistance 
training (Fig. 5.3D,F). 
Levels of FAK and its inhibitor, FRNK, per total protein were not altered by muscle overload, 
but the content of both was reduced at the mid- and end-point of the unloading protocol (Fig. 
5.2A,E). Microscopic examination visualized staining of FAK at the sarcolemma and locations 
in the sarcoplasma (Fig. 5.4). Sarcolemmal FAK immunoreactivity was significantly reduced 
after bedrest in type II muscle fibers (Fig. 5.4D). 
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Figure 5.2 Alterations in FAK in human vastuslateralis muscle with unloading. A,D) 
Representative detection of FAK and FRNK (A), vinculin isoforms (C) and beta 1 integrin (D) in 
western blots of 20 microgram total protein, and pY397 phosphorylated FAK in 
immunoprecipitates from 1 milligram soluble protein (B) of vastus lateralis muscle prior, mid 
and post bedrest. At the bottom of each panel the respective loading control (i.e. sarcomeric actin 
or IgG on the Ponceau S stained membrane) is shown. E, F) Median and SE of percentage 
changes in the content of FAK-related regulatory (E) and structural costamere proteins (F) per 
muscle protein during the time course of bedrest (n=9). + and * denote 0.05 ≤ p < 0.10 and p < 
0.05 vs. pre intervention levels (Wilcoxon-test). 
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Figure 5.3 Alterations in FAK in vastuslateralis muscle with increased loading. A-D) 
Representative detection of FAK and FRNK (A), vinculin isoforms (C) and beta 1 integrin (D), 
and FAK-pY397 (B) in vastus lateralis muscle prior, mid and resistance training. Respective 
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loading controls are shown at the bottom of each panel. E, F) Median and SE of changes in the 
content of FAK-related regulatory (E) and structural costamere proteins (F) per muscle protein 
during the time course of resistance training (n=6). + and * denote 0.05 ≤ p < 0.10 and p < 0.05 
vs. pre intervention levels (Wilcoxon-test). † and †† denote 0.05 ≤ p < 0.10 and p < 0.05, 
respectively, between fold changes mid vs. post the intervention (Wilcoxon-test). 
 
 
Figure 5.4 Localization of FAK to the sarcolemma.  
A, B) Example of a FAK-stained (red) section of vastus lateralis muscle in a subject before (A) 
and after (B) bedrest.Bar, indicates 100 micrometer. C, D) Enlarged images visualizing FAK 
signal(red) and type I myosin heavy chain-stained muscle fibers (blue) pre (C) and post 
unloading in vastus lateralis muscle of the same subject (D). The frames in panel A and B 
indicate the region enlarged in panel C and D, respectively. I, and II indicate examples of type I 
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and type II muscle fibers. + and - denote examples of FAK-positive and negativemuscle 
fibers.Examples of FAK-positive staining are indicated with white arrows.Nuclei appear in 
yellow. E) Bar graph showing median + SE of unloading-induced changes in the percentage of 
type I, and type II, muscle fibers showing FAK-immuno-reactivity. 1030 fibers from 4 subjects 
were counted. * denotes p < 0.05 post vs. pre bedrest levels (paired T-test). 
 
 
5.3.4 Associations between muscular changes with altered loading  
A number of linear relationships were identified between alterations in costamere protein content 
and muscle structure in the mid-point of atrophy and hypertrophy (Fig. 5.5B). This concerned 
correlations between percentage changes in beta 1 integrin content and muscle thickness (r=0.76). 
Similarly, changes in FAK-pY397, meta-vinculin and b1 integrin content were correlated to 
changes in CSA of type I fibers after resistance training (r>0.65).The changes in percentage of 
muscle area covered by type I fibers were positively correlated to changes in the costamere 
components gamma-vinculin, b1 integrin and type IIA MHC mid-way into altered loading, i.e. 
r=0.66, 0.65 and 0.96, respectively. Conversely, changes in FAK-pY397 content mid-way into 
altered loading were negatively correlated to those of MHCI content (r=-0.67). 
 
 
 
 
 
 
 
 
125 
 
 
 
A)                             B)                              C) 
  
 
Figure 5.5 Inter-relationship between muscular changes with altered loading.  
A-C) Correlation matrix of changes in assessed parametersin a given phase, i.e. ‘mid vs. pre’ (A), 
‘post vs. pre’ and ‘mid vs. post’ combined (B) and ‘post vs. pre’ (C) for the combined 
interventions. R-values are given in color-coding with those below 0.65 being blinded.  
 
 
5.4 Discussion 
 
 
5.4.1 An early and preferential hypertrophy of type I fibres was detected following 
resistance-training  
Skeletal muscle mass is highly sensitive to alterations in mechanical loading (Flueck and 
Goldspink 2010). A number of signaling factors/pathways, i.e. IGF-AKT-mTOR-p70S6K, 
FOXO, NF-KB, are implicated in the control of muscle anabolism and catabolism (Wilkinson et 
al., 2008, McCarthy and Esser 2010, Schiaffino and Mammucari 2011), whereby p70S6K is a 
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robust predictor for skeletal muscle growth (Baar and Esser 1999, Terzis et al., 2008). The 
anatomical basis for load-dependent signal regulation of muscle hypertrophy and atrophy is 
currently poorly understood despite the widespread view that this issue is considered of great 
importance (Adams et al., 2003, Chopard et al., 2009). Costameres, which reinforce the muscle 
fiber – extracellular matrix composite (Gullberg et al., 1998, Huijing 1999), are prime candidates 
for the organization of muscle signaling as they represent sites where the mechanical stress of 
force transmission is integrated into signaling (Ervasti 2003, Grounds et al., 2005). In order to 
address the role of costameres in the regulation of muscle size by mechanical loading, we 
assessed the association of level changes in the costamere’s components and its upstream 
regulator, FAK, with changes in muscle thickness and CSA following bedrest and resistance 
training.  
The present findings imply that the response to our resistance training paradigm involves an 
early and preferential hypertrophy of type I fibers. This is indicated by the tendency for an 
increase in the CSA of type I muscle fibers after 10 training sessions (3 weeks) concomitantly 
with the selective increase in content of MHCI at this mid-point of resistance training (Fig. 5.1F; 
Table 5.2B). With completion of the second phase of training, when training-induced increases 
in CSA of type II fibers were larger than in the first phase of training, changes in MHCI protein 
content fell to pre-training levels (compare Fig. 5.1F with Table 5.2B). Myofibrils form the 
larger part of muscle material (Luthi et al., 1986). It follows that the absence of significant 
changes in MHCI content per total protein in the second phase of hypertrophy with resistance-
type training reflects an increased incorporation of slow-type myofibrils being offset by 
elevations in CSA of type II myofibrils. This view is in line with slightly higher values of 
correlation between changes in muscle thickness and CSA of type I fibers compared with those 
127 
 
of type II fibers. It remains to be assessed to what extent this difference in type I and type II fiber 
hypertrophy reflects the earlier time point of our study compared with other investigations 
(Williamson et al., 2001, West et al., 2010) and/or the contribution of slow concentric- and 
eccentric-type contractions in the employed training paradigm (Seynnes et al., 2007). 
 
 
5.4.2 FAK protein level changes were found to differ between bed rest and resistance-type 
training  
Similar to our expectations, changes in the costamere regulator, FAK (Quach and Rando 2006), 
differed between bed rest and resistance-type training (Figs. 5.2E and 5.3E). The down-
regulation of FAK protein levels with unloading, which was reflected by reduced FAK C-
terminal immunoreactivity at the sarcolemma (Fig. 5.4D), reproduces our previous observations 
of load-regulated FAK expression and recruitment-related FAK staining at the sarcolemma 
(Gordon et al., 2001, Flueck et al., 2002, de Boer et al., 2007b, Evans et al., 2008). It is 
inconsistent with previous findings regarding the non-significant reduction in total FAK content 
with 10 days of unilateral limb suspension (de Boer et al., 2007b). Our findings in Chapter 4 
have also shown a reduction in FAK protein expression following 21 days of ULLS. 
Interestingly changes in the proxy of focal adhesion turnover in culture, i.e. FAK-pY397 content 
(Dumbauld et al., 2010), over all data points and at the end of resistance training correlated with 
changes in metavinculin (r=0.80; 0.85), and both parameters demonstrated an increase with 
resistance training (Fig. 5.3E,F). These findings are an indication of the implication of modified 
fiber adhesion in muscle remodeling with altered loading in men. 
 
 
128 
 
5.4.3 Concentration changes of costameric protein per total protein are inversely related to 
the changes in fiber radius 
Because myofibrillar mass largely contributes to total protein that serves as a reference for the 
estimation of total protein content, the increase in myofibrils with hypertrophy may camouflage 
(or dilute) any effect of resistance training on the amount of FAK. In this regard it is helpful to 
consider the geometric effects of atrophy and hypertrophy on the concentration of costameric 
proteins. As costameres reside at the fiber surface they scale to the fiber radius (i.e. 2r). By 
contrast, fiber volume that is the reference for total protein content is related to the square of the 
radius (i.e. r2). As a consequence, changes in fiber radius are expected to result in concentration 
changes of costameric protein per total protein that are inversely related to the change in fiber 
radius. Assuming that the expression of costamere components is not affected, the latter 
relationship is expected to result in negative correlations between individual changes in 
costamere proteins and in muscle (fiber) volume. This is in agreement with our finding of a close 
correlation (r=-0.86) between changes in vastus lateralis thickness and meta-vinculin content 
mid-way into bedrest. As a consequence, the absence of a significant increase in the 
concentration of structural components of costameres with bedrest may indicate that their 
expression is affected, yet this does not manifest at the level of content vs. total protein. 
Conversely, hypertrophy induced by resistance training could have been expected to result in a 
reduction of the concentration of costameric proteins. However, we detected an increase, which 
further emphasizes that expressional adjustments of costameres are load-dependent.  
 
 
5.4.4 Costamere components and muscle anatomy 
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The observed regulation of costamere components is of interest when put into the context of time 
course of changes in muscle (fiber) CSA with reduced and increased muscle loading. This 
comparison demonstrates that adjustments in the level of costamere components differ between 
the mid- and end-point of resistance training, and are matched to changes in muscle anatomy. 
The observed changes in costamere component content and micro- and macroscopic estimates of 
hypertrophy were specifically inter-related during the first phase of resistance training. For 
instance, the changes in metavinculin, b1 integrin and FAK-pY397 content were correlated to 
changes in mean CSA of type I fibres with resistance training (r>0.65). We also noticed 
correlations between the changes in the costamere component metavinculin and changes in 
muscle thickness mid-way into resistance training (r=0.79) and FAK with CSA post resistance 
training (data not shown). In addition, beta 1 integrin and muscle thickness were correlated up to 
the mid-phase, but not the end, of the combined response to overload and unloading (r-value of 
0.76 vs. 0.09). Taken together, the observations suggest that a possible structural reinforcement 
of costameres in the late phase of muscle hypertrophy contributes to the attachment of newly 
synthesized myofibrils after the integrin anchor is laid down, which is in line with the reported 
dependence of fiber growth in culture on costamere-mediated attachment of nascent myofibrils 
(Quach and Rando 2006, Konieczny et al., 2008). 
 
 
5.4.5 A decrease in the level of p70s6k was detected in the second phase of training 
The altered modality of muscle size regulation at the two time points of resistance training is 
supported by the reduced level of the serine/threonine kinase p70s6k in the second phase of 
training (Fig. 5.1C,D). It has been shown that post-translational activation of p70s6k is enhanced 
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after different types of training in both the trained and untrained state (Wilkinson et al., 2008) 
and is positively correlated with the degree of hypertrophy with resistance training (Terzis et al., 
2008). Surprisingly, changes in p70s6k content correlated negatively with changes in CSA of 
type II fibres after altered loading (r=-0.68; Fig. 5.5), and changes in muscle thickness after 
resistance training (r=-0.78) and after bed rest (r=-0.68). To our understanding it is currently 
unknown whether signaling is maintained through the prolonged response to altered muscle 
loading. Our data now suggest that expressional regulation of p70s6k may contribute to muscle 
protein accretion during resistance training in men (Coffey et al., 2006).  
 
 
5.4.6 Changes in content of costamere components in antigravity muscle can be regarded as 
markers for load-dependent muscle remodeling 
It has been previously suggested that maintenance of nitric oxide signaling mechanisms and 
changes in protein turnover can be regarded as biomarkers for human skeletal muscle atrophy 
with long-term bedrest (Salanova et al., 2008). We show here that changes in costamere-
associated muscle parameters, meta-vinculin, FAK-pY397 and MHCI, serve as indicators of 
muscle remodeling with altered loading in vastus lateralis muscle. This finding relates to the 
fiber type-specific localization of FAK and meta-vinculin to the sarcolemma (Flueck et al., 2002, 
Thoss et al., 2013). The observation is of interest, as one isoform of NO synthase as well is 
associated with costameres (Baum et al., 2000). Thus, our findings reinforce the notion that 
costamere components can serve as markers of load-dependent muscle remodeling. 
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5.4.7 Limitations  
A limitation of our study was that we did not quantify the localization of FAK at the sarcolemma 
as a function of muscle overload. This was due to an insufficient amount of high- quality bioptic 
sample to perform this characterization post-hoc. Also, we acknowledge that we did not assess 
an extensive list of costamere proteins for level alterations with increased and reduced muscle 
loading. Despite these constraints, we believe our findings provide novel information on the 
load-regulated content of structural (i.e. beta 1 integrin, vinculin and meta-vinculin) and 
regulatory factors of costameres in human subjects in relation to changes of muscle micro- and 
macro-structure. 
 
 
5.5 Conclusion 
Our observations point to a novel role for the organization of fiber adhesion in the mechano-
regulation of muscle size in men. Notably, two phases of costamere remodeling with resistance 
training can be distinguished by the expression of the integrin anchor and vinculin isoforms, and 
CSA of muscle fibers, but not at the macroscopic level by muscle thickness.  
 
 
 
6. Summaries, discussions and future directions 
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6.1 The effect of short-term unloading on protein expression patterns in two phenotypically 
distinct human leg muscles, m.vastus lateralis and m.soleus 
 
 
6.1.1 Summary of findings  
The study detailed in Chapter 3 was set out to explore potential early molecular changes at the 
protein level after only 3 days of reduced muscle loading. In line with our expectation, no 
significant change in MCSA of fibres was observed at such an early stage of unloading. Findings 
have demonstrated for the first time that elements of sarcolemmal focal adhesion complexes, i.e. 
costameres, are targets of early muscle fibre adaptation to reduced load-bearing, with indication 
for structural modification happening at just 3 days of ULLS. We found a tendency toward 
increased metavinculin content in soleus following unloading, which corresponds to the de novo 
expression of this protein in rat soleus after hindlimb suspension, as originally reported by 
Chopard and colleagues (Chopard et al., 2002). The group later detected the same adjustment in 
a long-term bed rest study (Chopard et al., 2005), where selective high protein content of 
metavinculin in a slow type muscle, soleus, rather than in a mixed type muscle, vastus lateralis, 
has been equally confirmed by my study in Chapter 3. The distinctive overexpression of 
metavinculin in slow-type muscle at unloading has been suggested as a sign of fibre type 
transformation in a slow-to-fast phenotype shift (Chopard et al., 2002).  
Upon detailed inspection of correlations between assessed factors, an overall muscle type 
dependent deregulation of protein expression in response to short-term unloading has been 
identified, before this is detected at the single-protein level. In particular, the present study 
demonstrated a muscle-specific transition in the correlation pattern of factors that reflect the slow 
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oxidative phenotype. For instance, there was a positive correlation between the levels of MHCI 
and mitochondrial proteins (SDHA, UQCRC1, and ATP5A1), and such typical relationship of a 
slow-oxidative muscle was later lost following unloading.  
This experiment is the first to have assessed chymotrypsin-like enzyme activity in human 
skeletal muscle during disuse situations.Whilst there were no significant alterations of its activity 
detected following 3 days of unloading in either muscles, our correlation analysis revealed the 
presence of a linear relationship between fold changes in the activity of chymotrypsin that 
constitutes a main component of the proteasome and the MCSA of type II fibres in the VL 
muscle after 3 days of ULLS (r=-0.71). Our finding is compatible with the previously identified 
upregulation of the mRNAs for the ubiquitin ligases, atrogin-1 and MuRF-1 (which direct the 
activity of the proteasomal pathway) in the VL compared with the SOL (Gustafsson et al., 2010), 
suggesting an enhanced capacity for proteasomal degradation of myofibrillar protein in VL 
muscle with unloading.  
 
 
6.1.2 Future direction 
An increased level of metavinculin has been observed in soleus following a short-period of 
ULLS. Given costamere's inherent structure for force transmission, as targets of early muscle 
fibre adaptation to reduced load-bearing, costameres might be structurally important for the 
regulation and initiation of mechano-dependent signalling, It is still very early to ascertain the 
true sgnificance of such finding since little information has been available to clarify the specific 
and distinct role of metavinculin as well as other components of costameres in skeletal muscle 
under atrophic conditions. Amongst the few existing studies, altered expressions of metavinculin 
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as well as other components of costameres during reduced functional demand have been reported, 
which suggest that these sarcolemmal focal adhesion proteins are targets of load-dependent 
muscle remodeling (Ervasti 2003, Chopard et al., 2005, Quach and Rando 2006). Further 
analysis on costameric proteins should serve to provide a better understanding of their functions 
in skeletal muscle fibre physiology. In particular, research focused on the role of costameres in 
functional and structural adaptations of skeletal muscle to altered mechanical strain is required.  
Although, we failed to observe significant change in chymotrypsin activity, interestingly, fold 
changes of its activity happened to negatively correlate with area content of slow type fibres and 
levels of two mitochondrial proteins (i.e. ATP5A1, UQCRC1) in VL but not in SOL, such 
observations could imply that the ubiquitin proteasome system functions to regulate slow-
oxidative fibre type in a muscle dependent manner at 3 days of human unilateral limb unloading. 
The muscle-specific response of early UPS activation is in line with Gustaffsson's work at 3 days 
of ULLS, where increased mRNA levels of MAFbx and MuRF1 were reported in vastus lateralis 
but not in soleus (Gustaffsson et al., 2010). In fact, UPS-mediated human skeletal muscle 
proteolysis is also evident from a previous study subjected to another short-term ULLS whereby 
2 days of immobilization triggered elevated expressions of MAFbx and MuRF1 (Reich et al., 
2010). However, according to the literature, the actual role of UPS in human disuse atrophy has 
not been fully elucidated due to a general lack of its enzymes’ protein and activity measures. 
Future studies should incorporate these assessments. 
It is well known that human skeltal mucle exhibits a load-dependent structural and functional 
plasticity, whereby, typical adjustment of metabolic and contratile compositions of muscle fibres 
manifests beyond two weeks of weightlless. However, according to the literature, majority of the 
data were generated over extended periods of muscle unloading as a result the onset of such 
135 
 
myocellular change wth unloading has not been clearly defined. The earliest documented 
molecular modification to date in humans involves mRNA epression alterations as a result, the 
quantitative significance of these pre-translational regulation, at early stages of disuse prior to the 
apparent muscle loss is not known (Chen et al., 2007, Gustafsson et al., 2010). The study 
detailed in chapter 3 was set out to explore potential early molecular changes at the protein level 
after only 3 days of reduced muscle loading. Given the results for Chapter 3, adjustments of 
assessed factors appear to have taken place earlier than previously reported. However, the 
outcome has been identified based on correlation analysis, hence future research providing 
information at the single protein levels on these factors is mmportannt in order to provide direct 
indications for their involvement. Such research should concentrate on understanding the events 
of the first few days of human muscle disuse. It was hypothesized that gene expression and 
signalling events known to control the atrophic process in cell culture and animal models could 
effectively take place in human skeletal muscle following just a few days of non-weight bearing, 
an understanding of early alterations in the underlying cellular and molecular basis of muscle 
adaptations to short-term unloading is pertinent in a way to promote the development of effective 
countermeasures and rehabilitation methods in situations where musculoskeletal unloading is a 
component.  
The results of our study show typical muscle-specific adaptive response to short-term unloading, 
Consistent with our observation, another 3 days ULLS study has identified differential protein 
turnover and pretranslational responses in the two phenotypically distinct muscles, m.vastus 
lateralis and m.soleus (Gustafsson et al., 2010). The author concluded that regulatory 
mechanisms, which initiate disuse induced muscle loss, are influenced by phenotype and/or 
function and he failed in an attempt to identify the underlyig mechanisms responsible for the 
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muslce specific atrophy in humans. Collectively, our work together with that from Gustaffsson's 
would hence demonstrate that regulatory machanisms, which initiate the disuse-induced changes, 
are influenced by phenotype and /or muscle function and could possibly involve multiple 
signalling pathways during initial stages of unloading. Future studies should aim to identify these 
signaling pathways. For this purpose, in part, potential transient changes and differential time 
courses for protein phosphorylation and gene expression should be acknowledged, such that 
early down-regulation of PI3K-Akt signalling has been reported to return to baseline level within 
around 72 hours whereas MAFbx and MuRF1 have a more sustained upregulation of over 10 
days (de Boer et al., 2007b). Therefore, experimental attention will need to focus on assessing 
the temporal regulation of potential signalling pathways, especially during the initial period of 
disuse. Aspects like the number of subjects or biopsies should be taken into careful consideration 
in future experiemntal designs. 
 
 
6.2 The regulation of anabolic and catabolic processes of human skeletal muscle in 
response to long-term unweighting  
 
 
6.2.1 Summary of findings 
In chapter 4 we have assessed several markers of muscle protein synthesis and degradation at 21 
days of ULLS. Distinct muscle atrophy has been confirmed by mean values of muscle fibre cross 
sectional area (MCSA), with a 14% decrease in type I fibre MCSA and a 21 % decrease in type 
II fibres MCSA of  m.vastus lateralis after ULLS, which is consistent with the general concept 
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that anti-gravity extensor muscles of the lower-limb experience the greatest atrophy in response 
to inactivity and unloading (Belavy et al., 2009). The reductions in MCSA of both fibre types  
were fibre-type independent (p=0.297), such observation is supported by an earlier experiment 
showing the rates of atrophy being unrelated to the proportion of type I muscle fibres (Blottner et 
al., 2006). Similarly another study has reported a preferential atrophy of the slow-oxidative type 
I fibres in rats, but not in humans. The author suggested that atrophy of fast type II fibres was 
comparable, if not greater than, that of slow type I fibres (Fitts et al., 2000). 
At the molecular level, there was a trend for a decrease in total focal adhesion kinase (FAK) 
protein, which happens to correspond with the observation of reduced levels of phosphorylated 
FAK and its protein content after 10 days ULLS intervention in humans accompanying a 50% 
decrease in the fractional rate of myofibrillar protein synthesis (de Boer et al., 2007b). We have 
also found that the content of FAK was positively correlated with the percentage of type I fibres 
and the percentage area content of slow fibres post ULLS. These correlations are the first human 
evidence to support the findings from animal studies of FAK as a load-dependent regulator of the 
slow-oxidative muscle phenotype. Our data reinforces the notion that FAK is an upstream 
modulator of a mechano-dependent anabolic pathway (Klossner et al., 2009). In fact, Flueck and 
colleagues have demonstrated from a rat muscle targeted transgenesis model that the downstream 
effector of the load-dependent FAK signaling in control of muscle mass is S6K (Klossner et al., 
2009). In chapter 4, the level of p70S6 Kinase did not alter at 21 days of ULLS. Although we 
haven’t measured the phosphorylated state of this protein due to the small size of the biopsies, 
which prohibited further biochemical molecular analysis, another recent study has reported no 
significant change with either phosphorylation of p70S6K at thr389 or its total content after 21 
days ULLS (De Boer et al., 2007a).  
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Apart from the anabolic signaling elements assessed, this study is the first to report a trend of 
increased chymotrypsin-like activity of the 20S proteasome as well as a trend of elevated 
cathepsin B/L enzyme activities in a disuse model in humans. These obervations are in line with 
the findings from animal unloading programs (Taillandier et al., 1996, Lecker et al., 2004, 
Ferreira et al., 2009, Fujino et al., 2009). In addition, strong positive correlations were found 
between the activity levels of cathepsin B/L and chymotrypsin-like enzymes post ULLS. 
Evidence has accumulated to show that both proteolytic pathways cooperate to degrade specific 
protein substrates and their activation corresponds with the net reduced proteolytic rate in animal 
models of disuse. More importantly, two in vivo studies now implicate thta FOXO transcription 
factors function to increase transcription of components of lysosomal and ubiquitin-proteasomal 
protein degradation systems (Attaix and Bechet 2007).  
 
 
6.2.2 Future direction 
In Chapter 4, we have observed a tendency for a reduction in total FAK protein content 
following 21 days of unloading. Currently, the majority of studies conducted were performed on 
rodents, with just two studies available to have assessed FAK in the reduced loading situations in 
human skeletal muscle ( de Boer et al., 2007b, Glover et al., 2008). Interestingly, in both studies 
the only change detected among the rest of measured signaling proteins was that of FAK, where 
de Boer's group observed a 30% decrease in FAK phosphorylation at Tyr 576/577 and a 20% 
decrease in its content after 10 days of ULLS and likewise to Glover's group a reduced level of 
phosphorylated FAK (Tyr 576/577) was detected after 14 days of unilateral knee immobilization. 
In addition, much of immobilization-induced muscle loss observed in the two studies was the 
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results of a decline in post-absorptive muscle protein synthesis (de Boer et al., 2007b, Glover et 
al., 2008). Collectively, these data closely reflect FAK's role based on cell and animal 
experiments as a mechano-transducer that induces downstream signaling molecules regulating 
protein synthesis. Future work will need to examine the temporal regulation of FAK activity 
under human skeletal muscle atrophic conditions. A better understanding to the mechanisms of 
FAK induced load-dependent anabolic signaling with particular focus on its regulation and 
downstream effectors in skeletal muscle are needed. These will help to verify the functional 
significance of FAK in human disuse muscle atrophy (Sakuma et al., 2009, Spangenburg 2009).  
S6k has been reported to be a downstream effector of the load-dependent FAK signaling in 
control of muscle mass. Suprisingly, we have not observed a change in S6K levels after 21 days 
of ULLS. Our observation has coincided with findings from another recent study, where no 
significant change with either phosphorylation of p70S6K at Thr 389 or its total content also 
after 21 days of ULLS was observed (de Boer et al., 2007b). The critical nature of S6K in 
muscle was initally demonstrated in the S6K knockout mice whereby the cross-sectional area of 
the individual muscle fibres was significantly smaller than that of fibres from the wild-type 
animals (Ohanna et al., 2005). In vitro studies have confirmed that S6K functions to promote 
skeletal muscle growth via controls over protein synthesis for increased translation capacity 
through phosphorylating downstream targets including S6 (Pende 2006). Furthermore, findings 
from several altered loading studies have shown that S6K activation is related to load-induced 
muscle mass increase and its decreased phosphorylation happens to correlate with reduced 
translation rate (Bodine et al., 2001b, Hornberger et al., 2001). However, only a few experiments 
have studied the relevance of animal findings of the functional role of S6K as an upstream 
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regulator of translation initiation in association with load-dependent skeletal muscle mass 
remodelling in humans. An accurate answer calls for further research in the human situation. 
Moreover, discrepancies have been oberved between animal and human data to date, as a result 
the role of S6K in load-dependent skeletal muscle remodelling remains unclear.  
In the future, researchers should consider the need for careful interpretation of the activation of 
S6K. The importance for such work to be undertaken is reinforced by a study, which has 
reported an increase in phosphorylated (thr421/ser424) S6K, when phosphorylation of S6 was 
rather unchanged. Such observations suggest the phosphorylation at thr42 1and ser424 as only 
the partial phosphorylation of s6k instead of a full phosphorylation to account for the activation 
of the enzyme (Koopman et al., 2006). Therefore, reports so far on increased phosphorylation of 
S6K are controversial in the way that selected phosphorylation sites might not be necessary or 
sufficient to indicate true s6k activation. Other poorly understood phospohrylation events 
contribute to s6k regulation. However, P70s6k phosphorylation in the 389 threonine end has 
been considered as a marker for increased protein synthesis induced by mechanical stimulation 
in animals (Baar and Esser 1999). Further interpretation must await new data on variables such 
as final activation of s6k (specially related to phosphorylation on residues responsible for the full 
activation of the enzymes) and protein synthesis or indirect markers of protein synthesis (eg. 
phosphorylation of ribosomal protein S6) to provide detailed information on the importance of 
s6k’s role during human skeletal muscle unloading. 
As part to understand the role of s6k in human disuse atrophy, the signaling mechanisms of its 
regulation need to be defined. Dufner and colleagues have proposed that current known signaling 
factors including PI3K, PDK1 and mTOR only partially activate p70s6k in vivo. Additional 
signaling pathway is responsible for full p70s6k activation status (Dufner et al., 1999). Further 
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research should aim to identify those regulatory molecules as well as to verify their relevance in 
human situations like the aforementioned case in FAK.On the other hand, other signaling 
systems might appear to compensate to fully rescue proliferation under chronic inactivation of 
s6k. Therefore it is highly advisable that future investigations should consider all the key 
components related to potential signaling pathways with consequences on protein synthesis.An 
effort to further explore alternative candidate pathways controlling human skeletal muscle 
wasting processes is required (Gustafsson et al., 2010). 
Furthermore, findings highlight the need to define its signaling activation patterns. Since 
unobserved change in S6K could simply reflect the time point when the biopsies were taken did 
not coincide with the transient change of the protein as suggested by the existing temporal 
relationship between s6k and its upstream regulator FAK through which enhanced FAK 
signaling triggers a delayed response of p70S6k py397. Differential time courses of activation or 
differential extents of signaling responses could explain the inconsistent comparison between 
findings from human subjects versus those observed in studies with rodents. In addition, it is 
interesting to note that according to one particular human study, the unchanged phosphorylation 
status of p70S6K observed following resistance training has been regarded as a response of 
negative feedback of p70S6k being auto-regulated by eIF-4E to reach cellular translational 
homoeostasis in a way to prevent uncontrolled growth rather than an indication of its inactivation 
during human skeletal muscle hypertrophy, giving rise to the idea that there might be a negative 
feedback of a similar sort to prevent uncontrolled muscle loss (Gautsch et al., 1998). 
It has been well established that a change in muscle mass is the result of an imbalance between 
protein synthesis and protein degradation. To date, the underlying regulatory mechanisms 
employed in human skeletal muscle disuse atrophy has not been resolved. The notion that disuse 
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atrophy of human skeletal muscle is primarily facilitated by compromised protein synthesis has 
been established for 20 years. However, increased protein breakdown have been indicated by 
measures of indirect indices of proteolytic activity in animal disuse atrophy studies where signs 
to suggest lysosomal degradation as well as ubiquitin proteasome proteolysis were observed 
(Taillander et al., 1996, Judge et al., 2007). Accumulating evidences have shown that both 
proteolytic pathways cooperate to degrade specific protein substrates and two in vivo studies 
now implicate that FOXO transcription factors function to increase transcription of components 
of the lysosomal and the ubiquitin-proteasome systems (Attaix and Bechet 2007). As a result, 
one of the aims of Chapter 4 was to measure the activity of these proteolytic systems in human 
disuse atrophy. We found that there was a tendency for an increased activity of cathepsins B/L, 
which is the first to be reported in a human disuse model. To date, very few studies have 
investigated the involvement of the lysosomal system in muscle atrophy and in light of the 
current findings future research should work to establish the role of lysosomal system in disuse 
atrophy of human skeletal muscle. 
Our results also showed a tendency to increased proteasome activity. In comparison to the wealth 
of knowledge gained from animal models concerning the function of UPS in load-dependent 
skeletal muscle remodeling, studies on humans are at a relatively early stage, with majority of 
the findings based predominantly upon transcriptional events. More specifically, it is the 
expression of the two E3 ubiquitin ligases, MAFbx and MuRF1, as the major regulators of 
muscle mass in various atrophic conditions including immobilization that were intensively 
examined (Murton et al., 2008, Foletta et al., 2011). In contrast to that of animal data, the 
distinctive increase in MAFbx and MuRF1 mRNA levels has not been consistently observed in 
humans (Murton et al., 2008). Apart from the question of whether a chosen animal model truly 
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represents the human situation, the inconsistency in findings could be explained by the fact that 
the timing of muscle sampling has failed to coincide with transient elevations of the E3 ligases 
and/or that only transcriptional changes have mainly thus far been examined. Therefore, 
differential, time -dependent changes at the transient level should be taken into consideration 
when coming to interpret these data. Above all, there is a major absence of protein measurements.  
Given the important findings from a couple of muscle wasting studies, where a dissociation 
between altered muscle proteolysis and genes expression changes of MAFbx and MuRF1 was 
observed, the presumption that their increased transcript levels represent concomitant rise in 
muscle proteolysis might prove unwarranted. As a result, the availability of protein content data 
is especially pertinent. Future study should assess both E3 ligases at the translational levels. 
Moreover, attention should focus on various other components of the ubiquitin-proteasome 
system. These approaches could help discern the functional relevance of UPS-mediated 
degradation to the human condition of muscle disuse atrophy. 
To date, the role of muscle protein breakdown in human muscle disuse atrophy remains 
equivocal. Our data from Chapter 4 revealed a likely involvement of both arms of muscle protein 
turnover, i.e., suppressed protein synthesis and activated protein breakdown at 21 days after 
ULLS. Such observation shares the same general view as those proposed in animal unloading 
models, where the underlying mechanism involves a combination of reduced protein synthesis 
and increased protein degradation, but it is not in concordance with some documented findings 
from human studies, where results demonstrate the notion that muscle atrophy is primarily 
facilitated by compromised protein synthesis. This suggestion has beeen established for 20 years. 
It was first reported in 1987 from a 7-week human immobilization experiment showing a 
profound fall in protein synthesis with no rise in protein breakdown, which was later confirmed 
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through disuse studies during the 14 to28-day time period (Gibson et al., 1987, Ferrando et al., 
1996, Paddon-Jones et al., 2006). Recently, de Boer and colleagues have detected a significantly 
reduced myofibrillar protein synthetic rate of 50% over 10 days with its lesser attenuation by 21 
days and a degree of 0.5% muscle atrophy per day over 23 days based on ULLS in young 
healthy men. The author concluded that considering the large decline in rate of myofibrillar 
protein synthesis it was unlikely for a rise in muscle protein degradation to take place over the 
entire period ( de boer et al., 2007b). On the contrary, there is less substantial evidence to 
support increased proteolytic activity being involved in disuse induced human muscle loss. 
However, several human studies have also observed upregulation of E3 ligases expressions, a 
component of UPS, in different periods of disuse, which is in line with the data from animal 
unloading programs (Taillandier et al., 1996, Lecker et al., 2004, Ferreira et al., 2009, Fujino et 
al., 2009). In fact, UPS-mediated human skeletal muscle proteolysis is evident from a previous 
study subjected to short-term ULLS whereby 2 days of immobilization triggered elevated 
expressions of MAFbx and MuRF1 (Reich et al., 2010). More recently, another human 
experiment has shown that ULLS triggers increased protein degradation as early as 3 days based 
on measures of indirect indices of proteolytic activity (Gustafsson et al., 2010). Overall, data 
highlight the pivital importance for detailed human studies to assess protein degradation in vivo. 
In order to discern the true relevance of protein breakdown in disuse atrophy, it is important for 
future research to provide more conclusive human data to address protein breakdown directly 
under muscle disuse atrophic conditions. There are essentially no direct approach to describe 
proteolysis in skeletal muscle loss since the required accurate and valid methodology to assess 
protein degradation in vivo in humans have unfortunately not been at hand. Previous report in 
1987 discovered unchanged protein breakdown in association with the distinctive muscle atrophy 
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over an extended period of 7 weeks of unilateral lower limb suspension in humans that was 
based on data inferred from differences in leg muscle mass and rates of protein synthesis (Gibson 
et al., 1987). Until recently, a lone study has determined the muscle contractile rate by means of 
a semi-invasive microdialysis technique, which involved measures of intramuscular 3MH 
content in vivo, allowing for the quantitative determination of proteolysis of the contractile 
elements actin and myosin in individual muscles. The resulting finding was an elevated 
interstitial levels of 3MH as a result of increased myofibrillar proteolysis after 3-day human 
ULLS (Tesch et al., 2008).  
 
 
6.3 Costamere remodeling with muscle loading and unloading in healthy young men 
 
 
6.3.1 Summary of findings 
The regulation of the content of structural and regulatory factors of costameres in human subjects 
in relation to changes of muscle micro- and macro-structure following bed rest and resistance 
training  were assessed in Chapter 6. An early and preferential hypertrophy of type I fibres have 
been observed after just 10 sessions of resistance training, whereby a tendency for an elevation in 
the CSA of type I muscle fibres was indicated together with a selective increase in content of 
MHC I. The costamere regulator, FAK protein levels in the first phase happened to be down-
regulated with unloading, which is in agreement with reduced FAK C-terminal immunoreactivity 
at the sarcolemma, such findings suggest a reduced capacity for FAK-regulated costamere 
remodelling during bed rest. Interestingly, adjustments in costamere components differed 
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between the mid- and end-point of resistance training. The observed regulation of costamere 
components is of interest when put in the context of time course of changes in muscle(fibre) 
CSA with reduced ad increased muscle loading. In particular, this comparison demonstrates that 
two phases of muscle remodelling were involved with resistance training. Thus, changes in 
costamere protein content and micro- and marcoscopic estimates of hypertrophy were 
specifically inter-related during the first phase of resistance training. For instance, changes in 
metavinculin levels and changes in muscle thickness were positively correlated at the mid-point 
of resistance training (r=0.79). Moreover, beta 1 integrin was correlated with muscle thickness 
only up to the mid-phase of the combined response to overload and unloading, such differences 
suggest that the upregulation of costameric proteins is related to a marked hypertrophic response 
after the 10th vs. 27th session of resistance exercise. An decrease in the level of p70S6k , a 
marker for muscle protein synthesis, in the second phase of training again support the 
observation of an altered modality of muscle size regulation at the two time points of resistance 
training. 
 
 
6.3.2 Future directions 
One of the findings reported in chapter 5 was that following just 10 resistance training sessions, 
there was an early and preferential hypertrophy of type I fibres. Future studies are needed to 
assess to what extent this difference in type I and type II fiber hypertrophy reflects the earlier 
time point of our study compared with other investigations (Williamson et al., 2001, West et al., 
2010) and/or the contribution of slow concentric- and eccentric-type contractions in the 
employed training paradigm(Seynnes et al., 2007). 
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A number of signalling factors have been implicated in load-dependent skeletal muscle 
remodelling, amongst which p70S6K is a major marker for anabolic signaling in skeletal muscle. 
Our findings suggest that expressional regulation of p70S6K may contribute to muscle protein 
accretion during resistance training in men at an earlier time point. However, surprisingly, in 
contrast to the idea that p70S6K should be positively related to the degree of hypertrophy our 
data showed that changes in p70S6K content correlated negatively with changes in CSA of type 
II fibers after altered loading (r=-0.68) (post vs pre ), and changes in muscle thickness after 
resistance training (r=-0.78) and after bed rest (r=-0.68). To our understanding, it is currently 
unknown whether S6K signalling is maintained through the prolonged response to altered muscle 
loading. Data from animal studies have suggested that the activation of S6K is related to gains in 
muscle mass induced by mechanical stimuli (Baar and Esser 1999, Nader and Esser 2001, Burry 
et al., 2007), and its low levels of phosphorylation are correlated with reduced translation rates 
(Bodine et al., 2001b, Hornberger et al., 2001). But, discrepancies exist between the observations 
made from animal studies and the few available human studies to date, such that one study has 
reported no significant change with either phosphorylation of p70S6K at thr389 or its total 
content in human skeletal muscle after 21 days ULLS (de Boer et al., 2007b). Overall, findings 
highlight the need to define S6K's signalling activation patterns. Therefore, future research 
should aim to elucidate the time course of S6k activation during altered loading conditions in 
humans with reference to changes in muscle size. Since such inconsistent comparison between 
findings from human subjects versus those observed in studies with rodents could simply reflect 
the time point when the biopsies were taken did not coincide with the transient change of the 
protein. 
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In the present study, we observed a reduced FAK c-terminal immunoreactivity at the sarcolemma 
with unloading. This observation is in line with the recent data from a human study where 
protein content and phosphorylation status of FAK were reported to decrease with reduced 
loading (de Boer et al., 2007b). Load-regulated FAK expression has been demonstrated in 
various animal-based studies but generally not in humans due to very little human research being 
carried out to date (Gordon et al., 2001, Flueck et al., 2002., de Boer et al., 2007b, Evans et al., 
2008). The level and phosphorylation of FAK have been reported to increase during load-
induced skeletal muscle hypertrophy, which is associated with increased myofibrillar content in 
vivo and in vitro animal studies (Flueck et al., 1999, Carson and Wei 2000). However, we failed 
to detect an increase in FAK content after resistance training. We believe such finding could 
demonstrate the fact that the increase in myofibrils with hypertrophy in response to resistance 
training can have a dilution effect on the actual elevation for FAK since myofibrilar mass count 
for a major/main proportion of total protein within a muscle tissue. Unfortunately, we were 
unable to quantify the localization of FAK at the sarcolemma as a function of muscle overload 
because of an insufficient amount of high-quality bioptic sample to perform this characterization. 
In this regard, future research should aim to assess the localisation of FAK at the sarcolemma in 
humans during unladoing as well as reloading conditions. 
The project has assessed level changes of a couple of costamere components in response to 
altered loading in humans. The results of which suggest that costamere components can serve as 
markers of load-dependent muscle remodelling and such notion can be supported by several lines 
of evidence generally from animal studies indicating that mechanical tension is critical in 
regulating costameric protein expression, stability and organisation. Costamere constituents talin 
and vinculin were shown to be upregulated in reponse to muscle contraction (Tidball et al., 
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1999). In addition, it has been reported that the normal transverse banding pattern of several 
costameric proteins (dystrophin, syntrophin and dystroglycan) was disrupted in skeletal muscle 
following 3 days of denervation, but was restored when the muscles were electrically stimulated 
(Bezakova and Lomo 2001). Moreover, the expressions of metavinculin and vinculin, two major 
components of costameres changed greatly under conditions of reduced functional demand in rat 
skeletal muscle (Chopard et al., 2002). Furthermore, dystrophin, vinculin and aciculin contents 
in skeletal muscles were found to increase after 7 and 21 days denervation and after 6 days 
spaceflight (Rezvani et al., 1996). One of the limitations of the current study is that we have only 
measured few of costamere proteins amongst the other proteins found in costamere include talin 
and alpha-actinin. In fact, over the past 20 years, an extensive list of costamric proteins has been 
documented (Ervasti 2003). Future research should explore the effects of unloading and 
reloading on a range of costamere proreins for level alterations in humans.  
Interestingly, our study has shown that the adjustments in the level of assessed costamere 
components (metavinculin, gamma-vinculin and beta1 integrin) happened to differ between the 
mid – and end-point of resistance training. By contrast, costamere protein level alterations did 
not change between the two time points of bed rest. To date the temporal response of costamere 
proteins to altered loading conditions has not been considered in humans. Whereas, data from 
animal models of disuse suggest that the changes in the relative contents of costamere 
components differ according to the duration of unloading. The relative vinculin content was 
observed to increase after 3 weeks of hindlimb suspension in rat skeletal muscles and more after 
6 weeks, which was in agreement with results for the dystrophin glycoprotein complex from 
another study (Chopard et al., 2001). On the other hand, the relative metavinculin content has 
been shown to decrease by 20% after 3 weeks unloading but returned to control levels 3 weeks 
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later (Chopard et al., 2002). Given these observations, future research should aim to assess the 
temporal response of costameric components under altered loading conditions in humans.  
Our study is the first to identify a function for FAK-mediated costamere remodeling in the load-
dependent regulation of muscle size in men through the association of level changes in 
costameres components with changes in muscle structure and molecular parameters of muscle 
size regulation following bed rest and resistance training. The observed regulation of costamere 
components is of interest when put in the context of time course of changes in muscle (fiber) 
CSA with reduced and increased muscle loading. Findings are in support for an altered modality 
of muscle size regulation at the two time points of resistance training. These findings could 
suggest a possible structural reinforcement of costameres in the late phase of muscle hypertrophy. 
Future experimentation should aim to better understand the regulation and function of FAK-
mediated costamere turnover in load-dependent skeletal muscle plasticity. 
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